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 PROŠIRENI SAŽETAK 
Helicobacter pylori je patogena bakterija nađena na sluznici čovjekova želuca. Danas se zna da 
je infekcija povezana s različitim ishodima bolesti. Iako su mnoge infekcije neprimjetne i bez 
ikakvih simptoma bolesti, većina rezultira s različitim stupnjevima gastritisa. U 10 % inficirane 
populacije zaraza će se razviti u teško želučano oboljenje poput peptičkog ulkusa (čira) te 
gastritisa. U 1 % zaražene populacije doći će do razvoja adenokarcinoma želuca te limfoma 
mukoznog tkiva (MALT). Stoga je 1994. Svjetska zdravstvena organizacija proglasila bakteriju 
H. pylori  karcinogenom I. reda [R. M. Jr Peek and M. J. Blaser, Nature Rev. Cancer 2 (1) 
(2002) 28–37; S. Suerbaum and P.N. Michetti, Engl. J. Med. 347 (2002) 11751186]. Genom 
sedamnaest sojeva bakterije H. pylori je u potpunosti sekvenciran, poput 26695, J99, G27 i 
HPAG1 [J. F. Tomb, O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. 
Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A.Dougherty, K. Nelson, J. Quackenbush, 
L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. 
Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. 
D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. 
Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. 
Smith, C. M. Fraser, and J. C. Venter, Nature 388 (6642) (1997) 539547; R. A. Alm, L. S. 
Ling, D. T. Moir, B. L. King, E. D. Brown, P. C. Doig, D. R. Smith, B. Noonan, B. C. Guild, 
B. L. deJonge, G. Carmel, P. J. Tummino, A. Caruso, M. Uria-Nickelsen, D. M. Mills, C. Ives, 
R. Gibson, D. Merberg, S. D. Mills, Q. Jiang, D. E. Taylor, G. F. Vovis, and T. J. Trust, Nature 
397 (1999) 176180; J. D. Oh, H. Kling-Backhed, M. Giannakis, J. Xu, R. S. Fulton, L. A. 
Fulton, H. S. Cordum, C. Wang, G. Elliott, J. Edwards, E. R. Mardis, L. G. Engstrand, and J. I. 
Gordon, Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 999910004; D. A. Baltrus, M. R. Amieva, 
A. Covacci, T. M. Lowe, D. S. Merrell, K. M. Ottemann, M. Stein, N. R. Salama, and K. 
Guillemin. J. Bacteriol. 191 (1) (2009) 447448]. Svi genomi imaju sličnu prosječnu duljinu i 
gustoću kodirajućih sekvenci. Ekstremno brza rekombinacija zajedno sa značajnom razlikom 
§ Prošireni sažetak xx 
 
sekvenci upućuje na panmiktičku strukturu populacije [S. Suerbaum and C. Josenhans, Nat. 
Rev. Microbiol. 5 (2007) 441452].  
Prema patološkoj važnosti bakterija H. pylori je u posljednjih dvadeset godina postala važan 
cilj istraživanja. Napravljene su i analizirane brojne interaktivne mape proteina iz bakterije H. 
pylori [J. C. Rain, L. Selig, H. De Reuse, V. Battaglia, C. Reverdy, S. Simon, G. Lenzen, F. 
Petel, J. Wojcik, V. Schachter, Y. Chemama, A. Labigne, and P. Legrain, Nature 409 (2001) 
211215] koji joj omogućavaju preživljavanje u kiselom mediju [L. Cendron and G. Zanotti 
Febs J. 278 (8) (2011) 12231231]. Suprotno prethodnom, broj podataka o riješenim 
strukturama proteina ove bakterije je malen: do ožujka 2016. u Protein Data Bank pohranjene 
su 439 datoteke s koordinatama atoma (http://www.pdb.org) dok su 33 datoteke u postupku 
pohranjivanja. 
U okviru ove disertacije strukturno je okarakterizirano nekoliko proteina važnih za 
preživljavanje bakterije H. pylori: FlgD, CrdA, HP1026.  
Pokretljivost stanice bakterije H. pylori uvjetovana je pravilnom strukturnom organizacijom 
biča. Bič se sastoji od otprilike 50 različitih proteina važnih za pravilnu regulaciju i udruživanje 
proteina, neophodnih za pokretanje stanice u bolje uvjete za preživljavanje [H. Zhou, M. Luo, 
X. Cai, J. Tang, S. Niu, W. Zhang, Y. Hu, Y. Yin, A. Huang, and D. Wang, Proteins 79 (7) 
(2011) 23462351]. Glavne komponente koje izgrađuju bič su: filament, kuka (engl. hook) i 
bazalno tijelo (engl. basal body) [O. A. Soutourina and P. N. Bertin, FEMS Microbiol. Rev. 27 
(2003) 505523]. FlgD pridonosi virulenciji bakterije H. pylori budući da je nužan za kontrolu 
pravilne strukturne organizacije kape biča (engl. hook cap) [W. T. Kuo, K. H. Chin, W. T. Lo, 
A. H. Wang, and S. H. Chou, J. Mol. Biol. 381 (1) (2008) 189199]. Do sada su riješene dvije 
kristalne strukture proteina FlgD iz bakterija Xanthomonas campestris [W. T. Kuo, K. H. Chin, 
W. T. Lo, A. H. Wang, and S.H. Chou, J. Mol. Biol. 381 (1) (2008) 189199] i Pseudomonas 
aeruginosa [H. Zhou, M. Luo, X. Cai, J. Tang, S. Niu, W. Zhang, Y. Hu, Y. Yin, A. Huang, 
and D. Wang, 79 (7) Proteins (2011) 23462351] međutim sličnost proteinskih sekvenci 
između navedenih homologa je manja od 20 %.  
CrdA (HP1326) je protein iz bakterije H. pylori važan za održavanje razine bakrovih iona u 
citoplazmi ispod toksične razine [B. Waidner, K. Melchers, F. N. Stähler, M. Kist, and S. 
Bereswill, J. Bacteriol. 187 (2005) 46834688]. Sve što se do danas zna o spomenutom 
proteinu su studije o RNA profiliranju [B. Waidner, K. Melchers, I. Ivanov, H. Loferer, K. W. 
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Bensch, M. Kist, and S. Bereswill, J. Bacteriol. 184 (2002) 67006708] koje upućuju na 
uključenost proteina u homeostazu bakrovih iona, međutim nedostaje stukturna karakterizacija.  
Geni za proteine koji se sintetiziraju uslijed izlaganja H. pylori termičkom šoku (engl. heat 
shock proteins; HSPs) organizirani su kao tri višecistronska operona. Njihova transkripcija 
kontrolirana je trima promotorima (Pgro, Phrc, Pcbp). Infekcija i prilagodba bakterije H. pylori 
ekstremnim uvjetima želuca omogućena je i spomenutim HSP-ima koji su uključeni u 
regulaciju aktivnosti ureaze i prijanjanje bakterijskih stanica za stijenku epitela želuca [D. 
Roncarati, A. Danielli, and V. Scarlato, J. Bacteriol. 193 (20) (2011) 56295636]. HP1026 
pripada ovoj skupini proteina i u potpunosti je neokarakteriziran stoga je razumijevanje funkcije 
ovog proteina iznimno važno. 
Cilj ovog istraživanja je strukturno karakterizirati proteine FlgD, CrdA i HP1026 iz 
bakterije H. pylori i potencijalno objasniti njihovu ulogu s naglasakom na razumijevanju 
funkcije spomenutih proteina pomoću podataka dobivenih strukturnom i biofizikalnom 
karakterizacijom. Prema dosadašnjim istraživanjima pretpostavke su: (1) FlgD kontrolira 
pravilnu polimerizaciju proteina FlgE koji izgrađuje kuku biča, (2) CrdA regulira razinu 
bakrovih iona u stanici ispod toksične razine te (3) HP1026 posjeduje ATP-veznu domenu. 
Rezultati istraživanja pridonijet će boljem razumijevanju uloge esencijalnih metala u strukturi 
i funkciji homeostaze, kontrole sinteze strukturnih elemenata biča bakterije te uloge proteina 
sintetiziranog uslijed izlaganja stanice termičkom šoku. 
Istraživani proteini (FlgD, CrdA i HP1026 iz organizma Helicobacter pylori) proizvedeni 
su u laboratoriju primjenom tehnologije rekombinantne DNA, ugradnjom u plazmidne vektore 
i prekomjernom ekspresijom genskih produkata u bakteriji Escherichia coli. Ispravnost 
ugradnje gena za željenu makromolekulu provjerena je sekvenciranjem, a identitet proteina s 
privjeskom utvrđen je western analizom. U slučaju kad je prisutnost His-privjesaka ometala 
ispravno formiranje kvaterne strukture željenog proteina, za kloniranje su korišteni drugi 
privjesci (GST-privjesak, Strep-privjesak) ili je privjesak bio uklonjen. GST-privjesak također 
pomaže i u topljivosti proteina koji bi u protivnom formirao inkluzijska tijela.  
Izolacija proteina iz bakterije E. coli započeta je razaranjem bakterijskih stanica 
sonikacijom ili razbijačem stanica (engl. cell cracker), te pročišćavanjem različitim 
kromatografskim metodama (afinitetna kromatografija, gel-filtracija), ovisno o prisustvu, 
odnosno odsustvu privjeska na proteinu. Čistoća završnog uzorka analizirana je korištenjem 
diskontinuirane denaturirajuće elektroforeze (SDS-PAGE). Koncentracija dobivenih proteina 
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određena je spektrofotometrijski, mjerenjem apsorbancije pri 280 nm, a prema teorijskim 
vrijednostima ekstinkcijskih koeficijenata, te izračunata prema Beer-Lambertovom zakonu. U 
slučaju velike razine ekspresije ali male topljivosti primjenjena je denaturacija i renaturacija 
proteina.  
Kružni dikroizam (engl. circular dichroism, CD) i jednodimenzijski NMR korišteni su radi 
dobivanja informacije o prisutnosti elemenata sekundarne strukture u proteinu što je iznimno 
važno nakon denaturacije i ponovne renaturacije proteina. Kvaliteta uzorka za kristalizaciju 
ispitana je metodom dinamičkog raspršivanja svjetlosti (engl. dynamic light scattering, DLS). 
Interakcija CrdA i bakrovih iona ispitana je UV-VIS titracijom dok je aktivnost proteina 
HP1026 (sposobnost hidrolize ATP-a) istražena praćenjem promjene apsorbancije produkta 
reakcije hidrolize ATP-a.  
Testiranje optimalnih uvjeta za nastanak kristala i optimizacija kristalizacije provedeni su 
metodom difuzije pare otapala iz sjedeće kapi upotrebom robota za automatsku kristalizaciju 
(Oryx8 robot) u nanolitarskoj skali (minimalna veličina kapi je 200 nL). Za kristalizaciju su 
korištene komercijalne kristalizacijske otopine, a nakon dobivanja prvih kristala kristalizacijski 
uvjeti su optimizirani u svrhu dobivanja kristala dobrih difrakcijskih sposobnosti variranjem 
različitih čimbenika (cijepljenje mikrokristalima, promjena temperature kristalizacije, dodatak 
aditiva, promjena omjera precipitanta i proteina u kristalizacijskoj kapljici, dehidracija kristala). 
Dobiveni kristali, ukoliko je bilo potrebno, namakani su u krio otopini, a potom skladišteni u 
tekućem dušiku. Snimanje kristala proteina obavljeno je na sinkrotronu ESRF (Grenoble, 
Francuska) ili SLS (Villigen, Švicarska) metodom rentgenske difrakcije na jediničnom kristalu. 
Kristalna struktura proteina riješena je bilo metodom molekulske zamjene (u slučaju postojanja 
dovoljno sličnog modela) ili metodom anomalnog raspršenja teškog elementa (u tu svrhu 
pripremljen je derivat proteina sa selenometioninom). 
Gen hp0907 ukloniran je iz dva različita bakterijska soja H. pylori (26695, G27). Proteini 
su pročišćeni do zadovoljavajuće čistoće te je gel-filtracijom i MALS eksperimentom (engl. 
multi angle light scattering) određeno da se cjeloviti proteini u otopini nalaze kao dimerne 
molekule. Jedinični kristali su pripremljeni metodom difuzije pare otapala iz sjedeće kapi 
korištenjem Oryx8 robota te su dobivene dvije različite kristalne forme skraćenog proteina 
FlgD. FlgD_G27 kristalizira u monoklinskom sustavu, P2 prostornoj grupi, a difrakcijski 
podatci su sakupljeni na sinkrotronskoj liniji ID14-4 (ESRF, Grenoble, Francuska) do 
razlučivanja od 2,75 Å. FlgD_26695 i SeMetFlgD_26695 kristaliziraju u tetragonskom sustavu, 
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I422 prostornoj grupi, a podatci su sakupljeni  na sinkrotronskoj liniji PXIII (SLS, Villigen, 
Švicarska) do razlučivanja od 2,17 Å u slučaju FlgD_26695 te do razlučivanja od 2,8 Å u 
slučaju SeMetFlgD_26695. Iako je u oba slučaja postavljena kristalizacija čitavog proteina 
(FlgD_G27 – 316 aminokiselina; FlgD_26695 – 301 aminokiselina), riješene kristalne strukture 
zajedno s rezultatima masene spektrometrije ukazuju da se u kristalnoj strukturi proteina 
FlgD_G27 i FlgD_26695 nalazi skraćen protein FlgD (Asn127  Lys272). Kristalne strukture 
proteina FlgD_G27 (HpFlgD_m) i FlgD_26695 (HpFlgD_t ) razlikuju se samo u dvije 
aminokiseline (257 i 268) i njihovim preklapanjem se dobije standardna devijacija između 146 
jednakih Cα atoma od 0,38 Å. U asimetričnoj jedinici HpFlgD_m nalaze se 4 molekule 
monomera i zauzimaju Vm = 2,63 Å3 Da1. Struktura sadrži oko 53 % otapala. Struktura 
HpFlgD_t ima u asimetričnoj jedinici samo 1 molekulu monomera i zauzima Vm = 3,26 Å3 Da1 
te udio otapala iznosi oko 62 %. Nadalje, kvaterna struktura u obje kristalne forme je tetramer 
koji je u strukturi HpFlgD_t generiran preko kristalografske osi četvrtog reda dok je u strukturi 
HpFlgD_m generiran nekristalografskom simetrijom. Dimeri se stvaraju preko kontakata -
lanca 9 i -lanca 12 tudor domena susjednih monomera, a takva situacija se ponavlja četiri puta 
stvarajući mrežu vodikovih veza između 4 molekule monomera. Rezultati dobiveni korištenjem 
PISA programa (engl. Protein interfaces, surfaces and assemblies) ukazuju da je takav tetramer 
vjerojatno postoji i u otopini. Razlika u oligomerizaciji cjelovitog proteina HpFlgD u otopini 
(dimer) i skraćenog proteina HpFlgD u kristalu (tetramer) može biti prisustvo N-kraja proteina 
blizu centra tetramera gdje se nalazi os četvrtog reda. Dulji N-kraj bi onemogućio stvaranje 
kontakata nužnih za tetramerizaciju. Kristalna struktura proteina FlgD je pokazala da se 
monomer sastoji od dvije domene, tudor i Fn-III domene, kao što je slučaj i u ostala dva 
homologa proteina FlgD čije su strukture riješene. Fn-III domenu izgrađuju aminokiseline 141 
– 234 dok tudor domenu čini 14 aminokiselina na N-kraju proteina (127 140) i ostatak 
aminokiselinskog slijeda na C- kraju proteina (235 – 272). Lys272 je posljednja vidljiva 
aminokiselina u strukturama monoklinske i tetragonske forme proteina HpFlgD. Međutim, 
značajna razlika je uočena u međusobnom položaju tudor domene u odnosu na Fn-III domenu 
u HpFlgD spram ostalim homolozima (XcFlgD i PaFlgD). Različita orijentacija domena 
između HpFlgD i ostalih homologa može upućivati na prisutnost dva prepoznatljiva 
orijentacijska modula koji predstavljaju dio mehanizma aktivacije proteina.  
Pretraživanjem Uniprot banke podataka uočeno je da sve sekvence homologa proteina FlgD 
u različitim vrstama roda Helicobacter sadrže prepoznatljive i neuređene regije na C-kraju 
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proteina redoslijeda XQK(X)2 (X = D / E / N; X2 = PI / PL / LS / PQ). Očuvane regije variraju 
samo u broju ponavljanja, a uvijek završavaju slijedom TPPKETA. Ovakav ponavljajući motiv 
nije pronađen u ostalim homolozima proteina FlgD, ali su slični motivi pronađeni u ostalim 
bakterijskim proteinima što može ukazivati na važnost takvog motiva u prepoznavanju 
proteinskih partnera. Štoviše, FliC protein (gradi filament biča) stvara interakcije preko svog 
C-kraja sa šaperonom FliS te se na taj način spriječava preuranjena polimerizacija proteina 
FliC. Također, nedostatak N-kraja u strukturi HpFlgD nije neobičan budući da ga i strukture 
ostalih homologa ne sadrže, a poznato je da FlgD iz bakterije Escherichia coli sadrži 71 
aminokiselinu kao signalnu sekvencu dok FlgD iz bakterije Salmonella enterica sadrži čak i 
100 aminokiselina kao signal za izlazak iz stanice. U prilog tomu da N-kraj proteina predstavlja 
signalnu sekvencu i da je zbog fleksiblnosti sklon degradaciji govori i analiza CD 
spektroskopijom koja je potvrdila da cjelovit protein HpFlgD sadrži  zavojnice (12,8 %) što 
je obilježje signalnih sekvenca. U riješenoj kristalnoj strukturi HpFlgD -zavojnice nisu 
prisutne. 
Priređeni su različiti genski konstrukti za ekspresiju proteina CrdA (Strep_CrdA, 
CrdA_His6 i GST_CrdA). Optimalna ekspresija proteina dobivena je pri nižoj temperaturi (16 
C), međutim u slučaju CrdA_His6 i Strep_CrdA dobivene su velike količine proteina u obliku 
inkluzijskih tijela dok je protein GST_CrdA prekomjerno eksprimiran s velikim udjelom u 
topljivim frakcijama. Kako bi se povećala topljivost proteina, uspješno su primjenjene metode 
za ponovno smatanje proteina, uključujući denaturaciju te renaturaciju polaganim 
razrjeđivanjem. Različite varijante rekombinantnog proteina su nadalje pročišćene afinitetnom 
kromatografijom i gel-filtracijom. Metodama kružnog dikroizma te jednodimenzijskog NMR-
a potvrđeno je postojanje elementa sekundarne strukture u renaturiranom proteinu. Na temelju 
analitičke gel-filtracije izračunata je molekulska masa proteina CrdA s His privjeskom u 
prisutnosti iona Cu2 (14,8 kDa). Dobivena vrijednost se podudara s predviđenom molekulskom 
masom (12,4 kDa) i odgovara postojanju monomernih vrsta u otopini. Dodatkom reagensa za 
keliranje metala (EDTA) dolazi do značajne promjene u ponašanju proteina CrdA, te tendencije 
proteina ka različitom stupnju oligomerizacije. Protein CrdA je ugušćen do maksimalne 
koncentracije,  = 9 mg mL1. Kvaliteta uzorka za kristalizaciju ispitana je DLS-om koji je 
ukazao na polidisperznost uzorka dok je dodatak deterdženta n-oktil--D-glukopiranozida 
(nOG) deterdženta i iona Cu2+ povećao monodisperznost uzorka. Afinitet iona Cu2 prema 
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proteinu CrdA ispitan je UV-VIS spektroskopijom te je izračunata Kd = 1,076  103 mol L1 
što upućuje na nizak afinitet prema ionima Cu2 što je karakteristika proteina koji prenose 
bakrove ione. Međutim, budući da aminokiselinski slijed CrdA obiluje metioninima, a ne sadrži 
histidin i cistein, potrebno je ispitati afinitet iona Cu+ spram CrdA. Za kristalizacijske 
eksperimente korišten je robot za automatsku kristalizaciju (Oryx8 robot). Pritom je korištena 
metoda difuzije pare iz sjedeće kapi te je ispitano 686 različitih kristalizacijskih uvjeta. 
Kristalizacijski eksperiment je u slučaju proteina CrdA u prisutnosti iona Cu2 i nOG-a 
rezultirao formiranjem malih kristala u uvjetu s PEG'S II SUITE (Qiagen) (0,1 mol L1,  Tris 
pH 8,5, (v/v) 16 % PEG 4000) pri 293 K. Difrakcijska mjerenja dobivenih kristala provedena 
su na liniji  ID23-1 ESRF sinkrotrona (Grenoble, Francuska) te su potvrdila da su nastali kristali 
proteina. Nažalost, kristali su slabo difraktirali (do razlučivanja od 20 Å), te je potrebna daljna 
optimizacija kristalizacije. 
Slijed aminokiselina proteina HP1026 sadrži očuvane sljedove aminokiselina 36 – 295 što 
svrstava protein u skupinu AAA proteina. Proteini iz spomenute skupine se odlikuju 
sposobnošću vezanja i hidrolize ATP-a, te sudjelovanjem u različitim staničnim procesima 
(transport i degradacija proteina, transkripcija, replikacija i sl.). Protein HP1026 uspješno je 
eksprimiran pri 28 C, te je zatim pročišćen afinitetnom kromatografijom i gel-filtracijom. 
Molekulska masa monomera HP1026 iznosi 43,8 kDa te je analitičkom gel-filtracijom 
ustanovljeno da su i Apo_HP1026 i kompleks HP1026:ATP--S prisutni kao dimerne vrste 
(96,9 kDa) u otopini, te da dodatak ATP--S ne potiče oligomerizaciju. Nadalje, ispitana je 
ATP-azna aktivnost HP1026, te su dobiveni sljedeći kinetički parametri: Km = 344 mol L1, 
Vmax= 0,6019 mol L1 s1, kcat= 0,02 s1. Dobivene vrijednosti se podudaraju s kinetičkim 
parametrima u slučaju aktivnosti proteina MgsA iz bakterije Escherichia coli. Analiza 
sekundarne strukture proteina CD metodom je pokazala da se HP1026 glavninom sastoji od -
zavojnica (44,5 %). Protein se pokazao kao izuzetno topljiv te je ugušćen do koncentracije veće 
od 40 mg mL1, a mjerenja DLS-om su pokazala da je uzorak proteina monodisperzan i pogodan 
za kristalizacijske eksperimente. Također je ispitana termička stabilnost proteina uz dodatak 
različitih aditiva, te je uočeno da ADP i ATP--S značajno povećavaju temperaturu mekšanja 
(Tm) proteina HP1026 i to za +3,52 C u slučaju dodatka ATP--S te za +5,18 C u slučaju 
dodatka ADP-a. Kristalizacijski eksperimenti postavljeni su korištenjem Oryx8 robota 
metodom difuzije pare otapala iz sjedeće kapi. Kristali heksagonskog oblika su dobiveni u 
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različitim uvjetima PACT SUITE (Qiagen), te su snimljeni na sinkrotronskoj liniji PXIII (SLS, 
Villigen, Švicarska) i pokazali slabu difrakciju (do razlučivanja od 15 Å). Uzevši u obzir 
rezultate o termičkoj stabilnosti proteina pokušala se optimizacija kristalizacije uz dodatak 
aditiva, te su dobiveni veći kristali u uvjetu 0,2 mol L1 NaBr, 0,1 mol L1 Bis-tris propan pH 
8,5, 20 % PEG 3350, 0,015 mmol L1  CYMAL-7 pri 20 C. Iako su kristali bili veći i uređeniji, 
difraktirali su samo do 7 Å što još uvijek nije dovoljno razlučivanje za rješavanje kristalne 
strukture proteina. 
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§ 1. INTRODUCTION 
The bacterium Helicobacter pylori colonizes the stomach of more than half of the world’s 
population.1 According to the National Center for Biotechnology Information (NCBI) the 
genomes of seventeen strains have been completely sequenced like 26695, J99, HPAG1 and 
G27.25 All of the genomes have similar average lengths of coding sequences and coding 
density. The extremely high recombination rate, in combination with a remarkable sequence 
diversity, has suggested a panmictic population structure.6 Approximately 10 % of the infected 
subjects will develop severe gastric pathologies, like peptic ulcer disease and atrophic gastritis. 
Approximately 1 % of infected individuals develop gastric adenocarcinoma and lymphoma of 
the mucosa-associated lymphoid tissue (MALT). The World Health Organization has declared 
H. pylori a class 1 carcinogen in 1994.79 
Due to its pathological relevance, H. pylori has become an important target for research in 
the last twenty years, since its first discovery: a large amount of literature has been produced 
on it, either from the medical or from the biological point of view; interaction maps of its 
proteome have been created10 and analysed and its ability to survive in the acidic environment 
has been investigated.11 On the contrary, structural data on the proteins of this bacterium are 
relatively limited: 439 files of atomic coordinates were present in the Protein Data Bank (PDB) 
in March 2016 (http://www.pdb.org), and 33 are waiting for release. Many proteins have not 
been characterized at all.  
Within this research several proteins from H. pylori, important for its survival, were  
characterized (FlgD, CrdA, HP1026). 
The flagellum is a protein complex composed of about 50 different proteins needed for its 
proper regulation and assembly. It provides the cell a chance to move to a more favorable 
environment and to avoid stressful conditions.12 Major sections that define the flagellum are: 
the filament, the hook and the basal body.13 FlgD plays an important role in H. pylori virulence, 
owing to its role in forming the hook cap component.14 Until now only two crystal structures 
of FlgD have been solved (from Xanthomonas campestris and Pseudomonas aeruginosa) but 
the protein sequence identity between FlgD from H. pylori and FlgD from the previously 
mentioned bacteria is less than 20 %.  
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H. pylori copper resistance determinant CrdA (HP1326) is required for keeping the 
concentration of free copper ions below toxic levels.15 At this moment there are no structural 
data on the CrdA protein and the only available studies are on RNA profiling.16 
Genes for heat shock proteins (HSPs) of H. pylori are organised in three multicistronic 
operons, transcriptionally controlled by three upstream promoters (Pgro, Phrc, Pcbp). Successful 
infection and adaption to the extreme gastric environment is also enabled by the heat shock 
proteins (HSPs) which are involved in regulation of the urease activity and adhesion to the 
epithelial cells.17 Since HP1026 is part of one of the heat shock operons controlled under the 
HspR regulator with an unclear function, investigation of its role is very important. 
Biophysical and structural characterization of the described proteins is crucial for 
understanding the function of these H. pylori vital proteins for survival in a highly acidic 
environment. The starting hypotheses of this work were: (1) FlgD controls the proper 
polymerization of FlgE inside the hook of the flagellum, (2) the CrdA protein is involved in 
maintaining the concentration of free copper ions below toxic levels and (3) the HP1026 protein 
possesses an ATP-binding domain.  
The goal of the doctoral dissertation was to structurally characterize FlgD, CrdA and 
HP1026, and taking into account their biophysical and structural properties to potentially 
demonstrate their function. The structural characterization was done by biophysical and 
structural analysis utilizing methods like thermal stability assay, circular dichroism, X-ray 
diffraction and 1D-NMR. To understand if CrdA exerts function of copper transport the 
interaction between the copper ions and CrdA was investigated by UV-VIS titration. To obtain 
experimental evidence on the role of HP1026, the ATP hydrolysis assay was performed using 
the reversed phase HPLC by measuring the change of the absorbance of the reactions products. 
The results obtained in this research widen our knowledge and contribute to better 
understanding of the role of the essential metal ions in the structure and function of 
metalloproteins, the control of proper flagellum construction, as well as the function of the heat 
shock protein. 
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§ 2. LITERATURE REVIEW 
2.1. Helicobacter pylori – an interesting medical target 
 
Helicobacter pylori (H. pylori) is a small (3.5 μm x 0.5 μm), slow growing, microaerophilic, 
non-spore forming and spiral-shaped Gram-negative rod bacteria (Fig. 1). The bacterium 
became an important and interesting target of research since it is known that it can colonize 
human gastric cells and lead to development of severe gastrointestinal diseases such as chronic 
gastritis, peptic ulcer disease, gastric mucosa associated lymphoid tissue (MALT) lymphoma, 
and gastric cancer.18,19 The bacterium was isolated and characterized at the beginning of the 
‘80s by scientists Marshall and Warren.20 It is known that more than half of the human 
population is affected with this bacterium.21 Moreover, this bacterium has accompanied humans 
for tens of thousands of years during migrations in the absence of a targeted antimicrobial 
therapy.7 It has been hypothesized that H. pylori colonization could have provided benefits to 
its human carriers and hence provided a selective advantage during long periods of human 
history.22,6,9 The infection with this bacterium is mainly transmitted from human-to-human 
possibly by the fecal–oral or oral–oral route. The infection can be spread vertically within 
families, generally in early childhood. While many H. pylori infected individuals are clinically 
asymptomatic, most will exhibit some degree of gastritis. Approximately 10 % of the infected 
subjects will develop more severe gastric pathologies, like peptic ulcer disease and atrophic 
gastritis. Approximately 1 % of infected individuals develop gastric adenocarcinoma and 
lymphoma of the mucosa-associated lymphoid tissue (MALT), a correlation that prompted the 
World Health Organization to declare H. pylori the first bacterial class 1 carcinogen in 1994.8,9 
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Figure 1. Electron micrograph of H. pylori. Spiral bacterial bodies with a bundle of sheathed 
flagella; bar = 1 µm, (taken from Yoshiyama and Nakazawa, 2002).23 
 
H. pylori genome is relatively small containing less than 1600 genes,2  in comparison to 
other Gram-negative prokaryotes, such as Escherichia coli and Salmonella enterica subsp. 
enterica serovar, whose genomes include more than 4000 genes.24,25 The genomes of seventeen 
strains of H. pylori have been completely sequenced, among them 26695, J99, HPAG1 and 
G27.25 Genome of the strain 26695 contains 1,667,867 base pairs. It is 24 kb larger than the 
J99 strain, which contains 1,643,831 base pairs, 71 kb larger than HPAG1, which contains 
1,596,366 base pairs and 15 kb larger than the G27 strain, which contains 1,652,983 base pairs. 
All the genomes have similar average lengths of coding sequences, coding density and the bias 
of initiation codons. Plausible cause of a wide genetic diversity could be explained by the need 
of H. pylori to adapt to the gastric conditions of its host as well as to the distinct patterns of the 
host immune response. 
 
2.2. H. pylori virulence factors 
 
Several pathogenicity factors like cytotoxin associated gene pathogenicity island (cag PAI), 
VacA vacuolating cytotoxin, urease, adhesins and outer membrane proteins are involved in 
virulence of H. pylori.26 Large diversity of H. pylori strains indicated that some of the strains 
are more virulent and can induce morphological changes and successive degeneration of in 
vitro-cultured cells.27 
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CagA was identified as a main marker for the evaluation of the strain pathogenicity and the 
presence of a genomic PAI. Cag PAI is a DNA fragment about 40 kb long which encodes for 
about 27 to 31 proteins, depending on the analyzed strain (Fig. 2).28,29 Eighteen proteins of cag 
PAI are involved in the structural organization of the type IV secretion system (T4SS) which is 
the main apparatus used in the infection process. T4SS enables penatration to the gastric 
epithelial cells and translocation of CagA, peptidoglycan and other bacterial effectors to the 
host cell.3032 After the injection of CagA into the host cells the protein becomes phosphorylated 
and starts to interact with more than 20 different human proteins included in signal 
transduction.33 This influences the proper function of epithelial cells like cell–cell adhesion, 
signalling, adherence and proliferation.34 The bacterial peptidoglycan delivered by T4SS 
triggers in the host cell the Nod1-response and induction of the nuclear factor-B pathway.35 
 
 
 
Figure 2. (a) Genes of the H. pylori strain 26695 that encode for the cag PAI. Numbers 
correspond to the HP0XXX number of the ORF represented by arrows;2 (b) schematic overview 
of the prototypal T4SS VirB ⁄ D from A. tumefaciens (left) and comparison with components of 
the Cag-T4SS from H. pylori (right). Cytoplasmic NTPases,  proteins forming the core trans-
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membrane complex and  pilus components are coloured in blue, various shades of green and 
yellow⁄orange, respectively. Integral transmembrane segments or proteins are shown as squares. 
The additional components that have been shown to participate in the Cag-T4SS complex are 
coloured in pink while the effector CagA that has been located at the tip of the pilus is coloured 
in black. The figure is adapted form Terradot and Waksman, 2011.32 
 
VacA is another protein classified as a pathogenic factor of H. pylori.26 In its active form it 
is a 95 kDa toxin responsible for massive vacuolization in gastric epithelial cells in vitro.36 
Moreover, it is shown that peptic ulceration and gastric cancer can be caused by secretion of 
VacA.37,38 Firstly, VacA is produced as a 140 kDa proprotein that is further cleaved into the 95 
kDa mature protein during the secretion. There is a significant difference in the pathogenicity 
of this toxin encoded by the vacA gene among the different H. pylori strains. VacA gene can 
encode for several types of VacA protein that has different composition of signal and middle 
regions (s1/m1, s1/m2, s2/m2). S1/m2 genotypes have the highest vacuolating activity and are 
more involved in the peptic ulceration and gastric carcinoma, while the s2/m2 genotypes lack 
the vacuolating activity.37 It is also interesting to highlight that even the specific vacA genotype 
of the same patient-strain combination shows a different expression level of VacA over time, 
showing the ability of rapid evolution of this bacterium to adapt its genetic material for 
persistent infection.39,40 When secreted, VacA forms pores in the membrane of the epithelial 
host cells allowing the release of urea, anions, cations and nutrients from the host cells. The 
VacA protein is also included in several cellular processes like induction of apoptosis (through 
the activation of the endogenous mitochondrial channels) and inhibition of T-cells activation 
and proliferation (Fig. 3). 
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Figure 3. The influence of VacA on several cellular processes and its involvement in the 
infection process of H. pylori. This figure is taken form Kusters et al., 2006.26 
 
Since H. pylori colonizes an acidic niche like gastric epithelial cells, regulation of acidity is 
an important mechanism of survival of this bacterium in these conditions. H. pylori survives in 
the range of pH 4  6.5 and thus this bacterium requires special mechanisms to adopt to the 
extreme acidic enviroment. Urease is the main enzyme that can increase pH by catalyzing the 
hydrolysis of urea that generates ammonia and carbon dioxide.26 Ammonia neutralizes the 
acidity inside the gastric lumen and forms a neutral microenvironment surrounding the 
bacterium (Scheme 1).41 
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         O                                                                          O 
          
NH3    H2N-C-OH H2N-C-NH2 + H2O                    
 
         O                                                                        
            
NH3    H2CO3 H2N-C-OH + H2O                    
 
H2CO3   H  HCO3 
2 NH3  2 H2O  2 NH4   2 OH 
 
Scheme 1. Hydrolysis reaction of urea catalyzed by urease. 
 
In general, urease can be found inside the cytoplasm of all other bacteria and plants,42 while 
the urease from H. pylori can also be present on the surface of the cell but only when it 
undergoes spontaneous autolysis.43 The role of cytoplasmic urease is protecting the bacterium 
from acidity because it could increase the periplasmic pH and membrane potential in 
combination with UreI, a proton-gated urea channel44,45 while the external urease is essential 
for survival of the acid-exposed organism. The crystal structure of nickel-containing urease 
from H. pylori (Fig. 4) shows that the protein is built from two different subunits -  and  ( 
- 61.7 kDa,  - 26.5 kDa) forming a heterotrimeric (αβ)3 assembly.46  
Urease 
Urease 
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Figure 4. Cartoon view of the crystal structure of urease from H. pylori (PDB ID: 1E97).46  
and  subunits are colored in yellow and pink, respectively, while the two nickel(II) ions are 
labelled as grey spheres. This figure was produced using CCP4MG.47 
 
Adhesins and outer membrane proteins are an additional class of H. pylori virulence 
factors.26 They are responsible for the adhesion of bacterial cells to the gastric epithelium. A 
list of part of the adhesion proteins involved in the infectious process is given in Table 1. 
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Table 1. Adhesins and their role in the pathogenesis of H. pylori  
Protein / gene 
cluster 
Predicted role Association with H. pylori 
related disease 
BabA Binds to fucosylated Leb blood group 
antigen on cells48 
babA2 allele has been 
implicated in peptic ulcer 
disease and gastric cancer49 
SabA Mediates binding to sialic acid 
containing glycoconjugates (sialyl-
Lex and sialyl-Lea antigens) and is 
involved in the activation of 
neutrophiles50 
 
SabB Unknown binding specificity Absence of SabB expression by 
the phase variation is involved 
in the development of duodenal 
ulcers51 
 
In addition to the previously described virulence factors, several other factors are important 
for the successful colonization and survival of H. pylori in the gastric epithelial cells such as 
motility, detoxification, metal ion homeostasis and heat shock regulation. They will be in more 
detail discussed in the next paragraphs. 
 
2.3. H. pylori flagellum 
 
H. pylori motility requires proper structural organization of 26 unipolar flagella.52 In order 
to survive in the hard stomach environment and to permanently colonize it, H. pylori has to 
move through the mucous layer and adhere to gastric epithelial cells, in particular during the 
initial phases of the infection53,54 and in doing so it has to rely on flagella.55,56 In contrast to 
many other Gram-negative bacteria, Helicobacter (and Campylobacter) species possess an 
unusual velocity in viscous media, possibly due to their helical shapes and to the presence of 
exclusively polar flagella.55 The structural organization and control of flagella in Gram-negative 
bacteria has been thoroughly studied.55, 5759 The complex flagellar structure is composed of 
approximately 30 different proteins, but many additional proteins (like chaperons and pumps) 
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are necessary for flagella expression and assembly, resulting in a total of at least 45 proteins 
(listed in Table 2).  
 
Table 2. H. pylori proteins involved in flagellum assembly (adapted from Pulić et al., 2014).60 
Location Protein 
name 
Name for 
strain 
26695 
Typology Role Complex Number 
of AA 
PDB-ID structure 
Export 
system 
FliO HP0583 Membrane protein Protein associated 
with FliP 
 293  
FliP HP0685  Protein associated 
with FliO and MS-
ring 
 153  
FliQ HP1419  Export component Associated 
with FlhA 
and FlhB 
88  
FliR HP0173  Associated with the 
MS ring 
 225  
FlhA HP1041  Target for soluble 
export proteins 
 733 3MYD 
FlhB HP0770  Target for soluble 
proteins 
 358  
FliH HP0353 Soluble protein Negative regulator 
of FliI 
The 
complex 
FliHIJ 
forms an 
ATPase 
complex 
258  
FliI HP1420  ATPase; export 
protein outside of C-
ring 
Interaction 
with FliH 
434  
FliJ HP0256  Putative protein  142  
FlgJ HP0245  Putative protein  105  
MS ring FliF HP0351 Transmembrane 
protein 
Transmembrane 
component of  rotor 
Associated 
with FlhA 
389  
C ring FliG HP0352 Cytoplasmic 
protein 
Rotor switch protein Associated 
with MotA 
FliM 
343 3USW; 3USY 
FliM HP1031  Involved in the rotor 
switch; binds the 
CheY-P protein 
N-terminus 
interacts 
with FliF 
354 4GC8, 4FQ0 
FliN HP0584  Flagellar export 
component; role in 
switching protein 
 106  
 FliY HP1030  Flagellar export 
component 
 283  
Stator 
 
MotA HP0815 Transmembrane 
protein 
Forms a proton 
channel through the 
membrane 
 210  
MotB HP0816   Associated 
with MotA 
257 3SO3, 3SOH 
(periplasmic region), 
3IMP, 3CYP, 3CYQ 
(C- terminal domain) 
P ring FlgI HP0246  Part of bushing  285  
L ring FlgH HP0325  Part of  bushing  237  
Proximal 
rod 
 
FliE HP1557  Has a role in rod 
stability during the 
growth; part of the 
export gate; MS ring 
rod junction protein 
 109  
FlgB HP1559    140  
FlgC HP15558    161  
Distal 
rod 
FlgF HP1092    269  
FlgG HP1585    262  
Hook-
filament 
FlgK HP1119 Soluble HAP1  606  
FlgL HP0295  HAP3  828  
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junction 
protein 
Filament 
capping 
FliD HP0752  HAP2  685  
Hook cap FlgD HP0907 Soluble Rod-modification 
protein; required for 
hook polymerization 
 301  
Hook FliK HP0906  Hook length 
regulator 
 77  
FlgE HP0870  Hook protein Helped by 
FlgD in 
polymerizat
ion 
718  
Filament FlaA HP0601  Flagellin subunit Polymerize
s with FlaB 
510  
FlaB HP0115  Flagellin subunit  514  
 HP1076   Interacts 
with FliS 
 3K1H 
FliS HP0753 Cytosolic protein 
specific for FlaA, 
FlaB 
  120 3IQC; 3K1I 
Regulato
ry protein 
FlgM HP1122  Encodes the 
inhibitor of 
flagellum σ28-factor 
 77  
FliA HP1032  Negative regulator 
of FlgM 
 255  
FlgR HP0730  Activates 
transcription with 
σ54-factor 
 381  
Chemota
ctic 
factor 
CheY HP1067  Chemotaxis  Interacts 
with FliM 
124 3GWQ; 3H1F; 
3H1G; 3H1E 
Chaperon FlgN HP1457  Chaperon FlgK-
FlgL 
 210  
FliT HP0754  Chaperon FliD  79  
FlgA HP1477 Periplasmic 
protein 
Chaperon involved 
in P-ring assembly 
 218  
Flagellar 
biosynthe
sis 
protein 
FlhF HP1035    459  
Flagellar 
assembly 
factor 
FliW1 HP1154    135  
Paralysed 
flagellar 
protein 
pFlA HP1274    801  
Flagellar 
assembly 
factor 
FliW2 HP1377    129  
 
The flagellum is a rotatory nano-machine that can be described as composed of two portions, 
the extracellular filament and the hook-basal body (Fig. 5). The latter represents the flagellar 
motor that converts the chemical into mechanical energy.57 The hook-basal body can be divided 
into three substructures: (1) the base, localized in the inner membrane and spanning to the 
cytoplasm; (2) the rod and ring structures, located in the periplasm; and (3) the hook, present 
on the surface. The assembly of the flagella and the stator requires proper interactions with the 
peptidoglycan layer through which the organelle has to pass for externalization.61 Roure et al. 
(2012)61 demonstrated that even though the flagella were correctly assembled, lack of the 
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appropriate lytic transglycosylase (MltD) resulted in incorrect localization of the flagellar motor 
protein HpMotB to the bacterial pole and with a loss of motility.  
 
 
 
Figure 5. Structural organization of the H. pylori flagellum (adapted from Pulić et al., 2014).60 
 
Until know little is known about the structure and assembly of flagellar proteins from H. 
pylori. Moreover, only seven 3D structures (including flagellar chaperons) have been 
determined so far (Table 2). 
The relevance of studying the molecular architecture of flagellar proteins is crucial for 
designing new therapeutic targets since flagella are components essential for bacterial 
colonization of the host. On the other side, the flagellum represents an ideal example of a 
molecular machine and the mechanism of conversion of chemical into mechanical energy.  The 
bacteria have been able to devise it during billion years of evolution and it can eventually be 
applied for nano-technological purposes. 
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2.3.1. The hook 
 
The hook, which is a tubular structure that connects the basal body to the extracellular 
filament, is made of about 120 copies of a single protein, called FlgE. Until now, only the crystal 
structure of FlgE from Salmonella enterica subsp. enterica serovar Typhimurium (PDB ID: 
1WLG)62 has been determined at 1.8 Å resolution. The structure corresponds to residues 71-
369 out of a total of 402. The crystallized fragment of FlgE lacks both the N- and C-terminal 
regions, since the full-length protein formed filaments and thus failed to crystallize. The same 
behavior occurs during the crystallization of the full-length flagellin protein. The group of 
authors that solved the crystal structure of FlgE built a model of the hook by using electron 
cryomicroscopy and image analysis, together with the docked crystal structure of FlgE. 
According to the density map, the hook is composed of three domains: the outermost domain 
at the surface (7.5 nm), the middle domain (5-6 nm) and the inner core domain that forms a 
tube (1 nm thick; 3 nm axial lumen).  
FlgE is a protein that tends to form filaments and, for this reason, it needs the presence of 
other proteins, FliK, FlhB and FlgD, in order to properly assemble the hook outside the external 
membrane of the bacterium.63 FliK is supposed to be involved in measurement of the correct 
hook length64,65 while FlhB (part of the type III secretion system, T3SS) is located in the inner 
membrane and helps the hook formation by interacting with the C-domain of FliK. When this 
interaction occurs, it induces a signal for termination of the export of proteins involved in the 
hook assembly and a signal for the export of proteins necessary for the filament formation.66 
There are also two proteins between the hook and the filament, called hook associated 
proteins - FlgK and FlgL. These proteins form a very short hook-filament junction zone, 
important for adapting these two mechanically different structures. The hook is relatively 
flexible, while the filament works as a propeller and for this reason has a much more rigid 
structure. According to this fact, those two proteins should share structural characteristics 
similar to the hook and filament proteins.  
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2.3.2. FlgD protein 
 
FlgD in Salmonella typhimurium is predicted to control the correct number of FlgE 
monomers that form the hook.67 In this bacterium FlgD is absolutely needed for the assembly 
of the flagellar hook, but it has not been detected in the mature flagellum.68 FlgD, like the 
majority of the flagellar extracellular components, is exported via a specific T3SS, located at 
the base of the flagellum. After assembly of the basal body in the cytoplasmic membrane and 
the C-ring in the cytoplasmic space, the flagellar export apparatus is built within the C-ring and 
gets ready to export the axial components, among which is FlgD, to construct the rod, hook, 
hook-filament and the long filament, according to this order.66 FlgD is associated to the 
apparatus when the rod is completed, but it is discarded as soon as the hook is completed, i.e. 
when FlgK is added to the hook. During this process the interaction between FlgE and FlgD 
may take place.69 
Two crystal structures of FlgD from other bacteria have been determined: Pseudomonas 
aeruginosa (PaFlgD, PDB ID: 3OSV)12 and Xanthomonas campestris (XcFlgD, PDB ID: 
3C12)14, Fig. 6. Both structures lack the N-terminal domain, which is predicted to be largely 
flexible, at least for the isolated proteins. A study of FlgD from Escherichia coli70 indicated 
that the first 71 N-terminal residues represent a signal for the export of the protein through a 
T3SS into the flagellar channel. T3SS is an essential part of the flagellum apparatus that allows 
the proper export of the proteins necessary for the assembly of the flagellum itself. In both FlgD 
structures monomer is composed of two domains rich in  strands: Fn-III nad tudor domains 
(Fig. 6). Kuo et al. (2008)14 performed DALI search against the PDB using the coordinates of 
the two separate domains of XcFlgD. They found that tudor domain superimposes well with the 
spinal muscular atrophy tudor domain and a number of chromo domain (a member of tudor 
family that can interact with specific methylated lysines in histones). Fn-III domain 
superimposes well with the Fn-III domain of cell adhesion and heparin-binding proteins.   
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Figure 6. Crystal structure of FlgD monomer from: (a) X. campestris (PDB ID: 3C12)14, (b) P. 
aeruginosa (PDB ID: 3OSV)12. This figure is produced using  CCP4MG.47 
 
2.4. Detoxification and metal ion homeostasis in H. pylori  
 
Regulation of metal ion homeostasis is of critical importance to all living organisms. 
Particularly, adaptation of H. pylori to the conditions in the gastric mucosa involves acquisition 
mechanisms that overcome a temporary lack of the metal ions. Metal ions have role in various 
biochemical reactions and both deficency and excess of particular metal ion can lead to the cell 
death or growth delay. Metal ions are cofactors of enzymes that catalyze reactions like electron 
transport, energy metabolism, redox reactions and are involved in the regulation of the osmotic 
pressure of the cell.26  
Nickel ions are essential for the proper structural organization and activity of the main 
pathogenicity factors, urease and hydrogenase. Moreover, several accessory proteins like 
HypA, HypB and UreG are needed for the maturaion of the [Ni,Fe] hydrogenase and urease.71,72 
In the acidic microaerobic environment H. pylori utilizes FeoB protein for transport of the 
ferrous ion (Fe2).73 Ferric reductase is another type of enzyme that reduces ions Fe3 to Fe2 
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which are then transported by the FeoB system. Beside the mentioned iron dependent enzymes, 
iron storage proteins in H. pylori have been characterized – Pfr ferritin and HP-NAP 
bacterioferritin. Pfr ferritin is a 19 kDa protein known to be responsible for the regulation of 
the concentration of free iron ions below the toxic levels as well as an iron deposit that can 
release and reuse the stored iron under the reduced iron conditions.74 Cobalt ions are also 
important for the activity of arginase enzyme which is involved in the nitrogen metabolism75 
and immune response of H. pylori. 
 
2.4.1. Copper ion homeostasis 
 
Besides nickel, iron and cobalt, copper ion is also an important cofactor in the regulation of 
metal homeostasis in H. pylori and plays significant role in electron transport, oxidases, 
hydroxylases and can mediate the formation of the oxygen reactive species. In addition, several 
proteins are involved in the transport of copper ions and control of concentration of free copper 
ions in the cytoplasm below toxic values. Among them are P-type ATPase CopA,76 HP1326 
(CrdA), HP1327 (CrdB), HP1328 and HP1329.16 An interesting study reported by Bereswill et 
al. (2000)77 suggested that the ferric uptake regulator (Fur) protein participates not only in the 
regulation of ferritin-mediated iron storage but also in the copper repression of Pfr synthesis. 
They showed that iron starvation, as well as medium supplementation with nickel, zinc, copper 
and manganese at nontoxic concentrations, repressed synthesis of ferritin in the wild-type strain 
but not in the H. pylori fur mutant. 
2.4.2. CrdA protein 
 
CrdA (HP1326) is a 13.8 kDa putative copper resistance determinant rich in methionines. 
In contrast to known copper chaperones, the protein sequence of CrdA lacks cysteine and 
histidine residues. Since CrdA is a secreted protein, it is predicted that it contains the first 20 
amino acids as signal peptide. Protein sequences of CopC from Pseudomonas syringae and 
CrdA from H. pylori share a common MXXMPGMP amino acid motif.  Crystal structures of 
the copper binding CopC protein from Pseudomonas syringae (PDB ID: 2C9Q),78 and 
Methylosinus trichosporium (PDB ID: 5ICU),79 revealed that this class of proteins can contain 
different binding arrangements: a canonical two binding site (Cu(II) and Cu(I)) or just a single 
Cu(II) binding site, Fig. 7.  
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Figure 7. Structure alignment of MstCopC (light pink) and PssCopC (purple). Copper ions are 
presented as blue spheres. This figure is taken from Lawton et al. (2016).79 
 
At this moment, there are no structural data on the CrdA protein and the only available 
studies are RNA profiling.16 According to the former study ORF HP1326 that encodes the H. 
pylori CrdA protein, showed a strong transcription activity upon increased copper 
supplementation while the nonheme iron containing ferritin (Pfr) synthesis was repressed (Fig. 
8). Similar behaviour was observed when the neighboring genes HP1327 (CrdB) and HP1328 
(CzcB) were inactivated. Other homologs of known copper regulation activity like E. coli 
CueR, Pseudomonas CopR/S and Ralstonia CzcRS are not present in the H. pylori genome. 
Taking all together, Waidner et al. (2002)16 proposed a novel type of copper efflux pump called 
Czc system that is consisted of copper resistance determinants CrdA (HP1326), CrdB 
(HP1327), CzcB (HP1328) and CzcA (HP1329), Fig. 8, which H. pylori requires for keeping 
the concentration of free copper ions below toxic levels. 
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Figure 8. Schematic overview of H. pylori responses to increased copper concentrations. 
Induction () and repression () of gene expression mediated by the increased copper pool are 
indicated by arrows. The putative composition of the Czc system of H. pylori HP1326 to 
HP1329 was constructed using the Ralstonia Czc system as a model. Putative location of CrdA 
(HP1326) protein is indicated in green. This figure is adapted from Waidner et al. (2002).16 
 
2.5. Heat shock proteins in H. pylori  
 
Heat shock proteins (HSPs) are, together with the transcription regulatory factors HrcA and 
HspR, another important factors of H. pylori successful infection and adaptation to the extreme 
gastric environment.80,17 These factors, besides their main role in protection of the bacterium 
from the environmental stresses, are also involved in the regulation of urease activity and 
adhesion to epithelial cells.81,43 Generally, Gram-negative bacteria like E. coli show positive 
regulation of HSPs through a specialized RNA polymerase 32 factor, which is absent in the 
genome of H. pylori. Opposite to the E. coli regulation, transcription control of HSPs in H. 
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pylori is negatively regulated by HrcA and HspR. The HSPs of H. pylori are organised in three 
multicistronic operons, transcriptionally controlled by three upstream promoters (Pgro, Phrc, 
Pcbp), Fig. 9. It has been demonstrated that under the normal growth conditions two regulators 
– HrcA and HspR are both needed to repress transcription from Phrc and Pgro promoters in an 
independent80 or cooperative manner82 while HspR by itself controls the Pcbp promoter. The 
same dual heat shock regulation is presented in Staphylococcus aureus where CtsR and HrcA 
synergistically repress transcription of dnaK and groESL operons.83 When H. pylori is exposed 
to heat shock the repression is blocked and HSP transcription is induced. Moreover, Roncarati 
et al. (2007)80 supposed that controlled synthesis of HSPs such as GroES, GroEL and DnaK 
chaperones could affect the flagellar assembly or other cellular structures and contribute to the 
proper motility. 
 
 
 
 
Figure 9. Structural organization of H. pylori heat shock operons and their transcriptional 
regulation controlled by HrcA and HspR regulators. Hp1026 gene (highlighted in red) is part 
of one of the heat shock operons regulated by HspR. This figure is adapted from Roncarati et 
al. (2011).17 
 
2.5.1. HP1026 protein 
 
HP1026 is an uncharacterized protein with an interesting gene location under the control of 
one of the heat shock promoters (Pcbp), and the HspR repressor. Two other genes, cbpA and 
hspR, that are located upstream of the hp1026 gene (Fig. 9) are regulated by the same promoter 
and repressor. It is known that cbpA codes for a homologue of cochaperone curved DNA-
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binding protein CbpA of E. coli84 while hspR codes for the negative regulator of Pgro, Pcbp and 
Phrc promoters.
85  
HP1026 is a 43.8 kDa protein that is according to UniProt database predicted to be a 
conserved hypothetical helicase-like protein. The protein is classified to belong to the AAA+ 
superfamily of ATPases. AAA+ designation describes protein involvement in processes like 
facilitation of protein folding and unfolding, assembly or disassembly of proteins complexes, 
protein transport and degradation, function in replication, recombination, repair and 
transcription.86 AAA+ superfamily comprises proteins that possess the conserved structural 
central ATPase domain of about 250 amino acids called the AAA+ module. The AAA+ domain 
is often divided into two structural subdomains, an N-terminal P-loop NTPase alpha-beta-alpha 
() subdomain that is connected to a smaller C-terminal alpha helical () subdomain. The 
 subdomain adopts a Rossman fold and contains several motifs involved in ATP binding 
and hydrolysis, including classical motifs Walker A and Walker B (Fig. 10).87 The  subdomain 
is much less conserved across AAA+ proteins. AAA+ proteins usually function as oligomeric 
rings, with a common hexameric arrangement that provides a hole through which DNA or RNA 
can be thread. 
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Figure 10. Crystal structure of the DnaA monomer belonging to the AAA+ superfamily from 
Aquifex aeolicus (PDB ID: 2HCB)88 (a) The α-helices and random coils (colored green) and 
the β-strands (colored blue) of the core αβα nucleotide-binding domain, with the exception of 
the two equal-sized helical inserts, which are colored pink. The small α-helical domain is 
colored purple. (b) Major motifs in the AAA+ module are colored as indicated in the legend. 
The bound adenosine 5'-[β,γ-methylene]triphosphate (β,γ-methylene-ATP, a nonhydrolyzable 
ATP analog, orange sticks) and Mg2+ (black sphere) are also shown. This figure is adapted from 
Snider et. al (2008).87 
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H. pylori HP1026 shares an overall amino acid identity of 31 % and 26 % with E. coli MgsA 
(maintenance of genome stability protein A) and Archaeoglobus fulgidus RFC (replication 
factor C), respectively. MgsA and RFC are proteins involved in the process of DNA replication 
while according to the UniProt database, HP1026 is supposed to be a helicase like protein. 
EcMgsA is important in facilitating the recovery of stalled replication forks while AfRFC is 
involved in opening and closing the DNA polymerase processivity factors onto DNA. Although 
the amino-acid sequence homology is low between HP1026 and described proteins the 
conserved fold of the nucleotide–binding domain is present in them like in HP1026. Crystal 
structures of EcMgsA (PDB ID: 3PVS)89 and AfRFC (PDB ID: 2CHQ)90 revealed that both 
proteins possess an ATP binding site, as it is also predicted for the HP1026 protein. The 
EcMgsA monomer is composed of three domains: ATP binding and helical lid domains 
(conserved among AAA+ proteins), and a tetramerization domain. The AfRFC protein is built 
of conserved AAA domains 1 and 2, while domain 3 forms a five-helix bundle. As common 
for the AAA+ proteins, AfRFC oligomerizes as a hexamer.  
In general, H. pylori helicases are poorly structurally charaterized. So far the only known 
crystal structures of H. pylori helicases are of proteins DnaB, a dodecameric replicative helicase 
(PDB ID: 4ZC0),91 and of a helicase binding domain of the DnaG protein (PDB ID:4EHS).92 
This finding places structural investigations on the H. pylori helicase-like proteins in a 
challenging field of research. 
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§ 3. MATERIALS AND METHODS 
3.1. Materials 
 
3.1.1. Equipment 
 
Table 3. Devices and instruments (basic laboratory equipment is not listed). 
 
Instrument Manufacturer 
ÄKTA Purifier GE Healthcare 
Avanti J-25 centrifuge Beckman Coutler 
Shaker Thermo Scientific 
Spectrophotometer Evolution 60 Thermo Scientific 
One Shot Cell breakage system Constant System Ltd., UK 
Eppendorf centrifuge Eppendorf 
Vibra Cell Homogenizer Bioblock Scientific 
Ultrasonic bath Elma 
Electrophoresis Mini-PROTEAN Tetra System  BioRad 
Heating/cooling dry block CH 100 Biosan 
Nanodrop 1000 Thermo Scientific 
Electrophoresis system 2117 Multiphor II LKB 
Oryx 8 robot Douglas instruments 
DLS, Zetasizer Nano ZS Malvern Instruments Ltd 
MALS, Astra 6.1 miniDAWN TREOS 
QuadrupoleTOF spectrometer Waters, Manchester, UK 
Spectropolarimeter  Jasco Analytical Instruments 
Microscope SZX 12 Olympus 
UV fluorescence microscope MZ16F Leica  
T100 Thermal cycler  Bio-Rad 
Real time PCR Applied Biosystems 
Molecular imaging system Carestream Health, Inc. 
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3.1.2. Chromatography supplies 
 
Table 4. Columns, media and molecular weight markers used for affinity and size-exclusion 
chromatography. 
 
Chromatography supplies Manufacturer 
PD-10 desalting columns GE Healthcare 
His Trap Ni-NTA agarose GE Healthcare 
GSTrap GE Healthcare 
Strep-Tactin IBA 
Gel filtration molecular weight markers Sigma Aldrich 
 
3.1.3. Crystallographic supplies 
 
Table 5. Crystallization screens. 
 
Screen Manufacturer 
PEGs II, PACT SUITE, JCSG Core (Suites IIV) Qiagen 
Structure Screen 1 & 2, PGA Screen, Solubility Tool Kit Molecular Dimensions 
Additive Screen Hampton Research 
 
Table 6. Crystallization plates. 
 
Type Manufacturer 
MRC 96-well sitting drop crystallization plate  Molecular Dimensions 
MRC MAXI 48-well sitting drop 
crystallization plate 
Molecular Dimensions 
24-well XRL plate Molecular Dimensions 
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Table 7. Cryocrystallography equipment. 
 
Type Manufacturer 
Mounted CryoLoops Molecular Dimensions 
EMBL/ESRF sample changer kit  Molecular Dimensions 
Mounted Mesh LithoLoop Molecular Dimensions 
 
3.1.4. Kits 
 
 
Table 8. Kits used for preparation of DNA and for staining of the gels for visualizing proteins 
according to the manufacturers’ protocols. 
 
Type Manufacturer 
QIAprep Spin Miniprep Kit Qiagen 
QIAquick Gel Extraction Kit Qiagen 
ProteoSilver Silver Stain Kit  Sigma Aldrich 
 
3.1.5. Filters and membranes 
 
Table 9. Ultra centrifugal filters used to concentrate dilute protein solutions, membranes used 
for filtering sterile aqueous solutions and transfer membrane used for western blotting. 
 
Type Manufacturer 
Amicon Ultra centrifugal filter units with a molecular 
weight cut-off of 3 kDa,10 kDa and 30 kDa, respectively. 
Millipore 
0.2 μm cellulose acetate membranes Millipore 
PVDF membrane, 0.2 μm Millipore 
 
3.1.6. Chemicals and buffers 
 
All buffers were prepared with redistilled water (MilliQ gradient water system) and then filtered 
using a Sartolab filter system with PES membrane (0.22 µm pore size). If not stated otherwise, 
all chemicals were obtained in analytical grade from the following companies: Acros Organics; 
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AppliChem; Carl Roth; Fisher Scientific; Fluka; Jena Bioscience, Merck, Roche GmbH 
(Mannheim); Serva Electrophoresis; Sigma Aldrich. 
 
3.1.7. Enzymes 
 
Restriction enzymes and polymerases for molecular biological applications as well as proteases 
for biochemical usage were obtained from New England Biolabs (NEB), Sigma Aldrich and 
ThermoFisher Scientific. All enzymes were used in their appropriate buffer as specified by the 
manufacturer. 
 
Table 10. Features of enzymes used for molecular and biochemical applications. Recognition 
sequences of restriction enzymes and proteases are in superscript. 
 
DNA modifying enzymes Application Manufacturer 
Phusion high-fidelity DNA 
polymerase 
 
Amplification of DNA 
(proofreading) 
ThermoFisher 
Scientific 
Taq DNA polymerase  Amplification of DNA 
(no proofreading) 
ThermoFisher 
Scientific 
T4 DNA ligase Ligation of DNA 
fragments 
ThermoFisher 
Scientific 
BamHI5' G|GATCC 3' Restriction of DNA NEB 
XhoI5' C|TCGAG 3' Restriction of DNA NEB 
DNase I Digestion of DNA Sigma Aldrich 
Rnase A Digestion of RNA ThermoFisher 
Scientific 
Trypsin K, R (on –COOH terminus) Proteolysis Sigma Aldrich 
- Chymotrypsin Y, W, F, L, M (on –COOH terminus) Proteolysis Sigma Aldrich 
- Thermolysin L, F (on –NH2 terminus) Proteolysis Sigma Aldrich 
Thrombin LVPR|GS Removal of His6-tag 
present at protein 
Novagen 
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expressed in vector 
pET 15b / Proteolysis 
Prescission ProteaseLEVLFQ|GP Removal of GST-tag 
present at protein 
expressed in vector 
pGEX-6P-1 
Sigma Aldrich 
 
3.1.8. Antibodies 
 
Table 11. Features of primary and secondary antibodies. 
 
Primary antibody Secondary antibody Application Manufacturer 
Monoclonal Anti-
His6 (mouse)  
Detection of 
HHHHHH-epitope in 
proteins  
Roche 
 
Polyclonal Goat anti-
Mouse Antibody, 
horseradish 
peroxidase (HRP) 
conjugate 
 
 General Electrics 
 
3.1.9. Oligonucleotides 
 
Oligonucleotides (Table 12) were synthesized by Sigma-Aldrich. The lyophilized and desalted 
oligonucleotides were dissolved in sterile water at a concentration of 100 μmol L1 and stored 
at 20 °C. 
 
Table 12. Oligonucleotides used as primers to amplify gene sequences. 
 
Name Sequence (5' to 3') Application 
GST_HP1326-for 
GST_HP1326-rev 
GAGAGAGGGATCCATGCAAACCCTAAAAGCCAAC 
GAGAGAGCTCGAGTTATAAATCCAGGCTTGTTTTTAG 
Amplifying 
GST_HP1326 
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Strep_HP1326-for 
 
Strep_HP1326-rev 
GAAGGAGATATACATATGTGGAGCCACCCGCAGTTCGAAAA
ACAAACCCTAAAAGCCAAC 
GTGATGGTGGTGATGATGTTATAAATCCAGGCTTGTTTTAGC 
Amplifying 
Strep_HP1326 
HP1326_His-for 
HP1326_His-rev 
GAAGGAGATATACATATGCAAACCCTAAAAGCCAACGAC 
GTGATGGTGGTGATGATGTAAATCCAGGCTTGTTTTAGC 
Amplifying 
HP1326_His 
HP0907_His-for 
HP0907_His-rev 
GGAGATATACATATGGCTATTGATTTAGCAGAAG 
GTGATGGTGGTGATGATGTGCTGTCTCTTTAGG GG 
Amplifying 
HP0907_His 
 
3.1.10. Vectors 
 
pET15b (Novagen), Fig. 11 and Table 13, is a 5708 bp long vector that carries a N-terminal 
hexa His-tag sequence followed by a thrombin recognition site and MCS, including sites for 
XhoI, BamHI and NdeI. Expression of genes cloned into this vector is under the control of the 
T7-lac promoter. Additionally, the vector carries an ampicillin resistance gene (ampR) for 
selection.93  
 
pGEX-6P-1 (GE Healthcare), Fig. 11 and Table 13, is a 4984 bp long bacterial vector for 
expression of N-terminal GST-tagged recombinant proteins under the tac promoter. The vector 
contains a PreScission Protease recognition site for cleaving the protein from the GST-tag and 
an ampicillin resistance gene (ampR) for selection.94 
 
pETite C- His (Lucigen), Fig. 11 and Table 13, is a 2235 bp long pre-processed vector that 
encodes the C-terminal hexa His-tag. The vector includes a kanamycin resistance gene (kanR) 
for selection and inducible expression under control of the T7-lac promoter.95 
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Figure 11. Schematic presentation of plasmid vector maps used for cloning. 
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Table 13. List of all designed constructs with starting and ending positions of the amino acid 
residues. 
 
Protein Template Vector Start End 
HP1326 (CrdA) H. pylori G27 pETite C-His 23 125 
  pGEX-6P-1 23 125 
HP1026 H. pylori G27 pET15b 1 391 
HP0907 (FlgD) H. pylori G27 pETite C-His 1 316 
 H. pylori 26695 pETite C-His 1 301 
 
3.1.11. Bacterial strains: Escherichia coli 
 
3.1.11.1. Host strain for cloning 
 
One Shot TOP10 (F mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ lacX74 recA1 araD139 
Δ(araleu)7697 galU galK rpsL (StrR) endA1 nupG) (Invitrogen) are chemically competent 
cells that allow stable replication of high-copy number plasmids.96 
 
DH5 (F Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk, mk) phoA 
supE44 thi-1 gyrA96 relA1 λ) (Invitrogen) are chemically competent cells that allow 
blue/white screening on plates containing either X-Gal or Bluo-Gal due to the Φ80lacZΔM15 
genotype. Moreover, the recA1 mutation helps to reduce the rate of recombination while 
propagating plasmid DNA, and the endA1 mutation prevents unspecific digestion of DNA.96 
 
3.1.11.2. Strains for protein expression 
 
BL21 (DE3) (F ompT hsdSB (rB-mB-) gal dcm (DE3)) (Invitrogen) are chemically competent 
cells deficient in both lon and ompT proteases. The designation (DE3) indicates that the host is 
a lysogen of λDE3, and therefore carries a chromosomal copy of the T7 RNA polymerase gene 
under control of the lacUV5 promoter. Such strains are suitable for production of protein from 
target genes cloned in pET vectors using IPTG as an inducer.97 
 
BL21pLysS (DE3) (F ompT hsdSB (rB-mB-) gal dcm (DE3) pLysS (Cam
R)) (Invitrogen)) are 
chemically competent cells used to suppress basal expression of T7 RNA polymerase prior to 
induction and thus stabilize pET recombinants encoding target proteins that affect cell growth 
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and viability. The pLysS designation is given to hosts carrying a pET-compatible plasmid that 
encodes T7 lysozyme, which is a natural inhibitor of T7 RNA polymerase.97 
 
3.2. Microbiological methods 
 
3.2.1. Media for cultivation of E. coli cells 
 
Liquid cell cultures of E. coli were grown in LB (Luria Bertani) medium (0.5 % NaCl, 0.5 % 
yeast extract, 1 % tryptone, all w/v). Solid media were additionally supplied with 1.5 % (w/v) 
agar. All media were sterilized by autoclaving for 20 min at 120 °C. If necessary, appropriate 
antibiotics were added prior to use: for cells harboring pET15b and pGEX-6P-1 based vectors, 
ampicillin was added at a concentration of 100 μg mL1. Cells containing the pETite C-His 
plasmid were selected using 30 μg mL1 kanamycin . 
 
3.2.2. Transformation of chemically competent E. coli cells 
 
Chemically competent cells (50 μL) were thawed on ice, mixed with 50300 ng DNA and 
incubated on ice for 30 min.  Afterwards the cells were heat shocked for 1 min at 42 °C and 
then placed on ice for further 2 min. After addition of 300 μL of LB medium, the cells were 
shaken at 37 °C for 4560 min. The cell suspension was plated onto LB-agar plates supplied 
with appropriate antibiotics and incubated at 37 °C overnight (o/n). 
 
3.3. Molecular biology methods 
 
Experiments handling preparation and isolation of DNA were performed according to the 
instructions from the laboratory handbook J. Sambrook and D. Russell: Molecular Cloning: A 
Laboratory Manual, 3th edition, Cold Spring Harbor Laboratory Press (2001),98 or according to 
the datasheet instructions of the specific chemical/kit that was used. 
 
3.3.1. Amplification and isolation of plasmid DNA from E. coli 
 
Isolation of plasmid DNA was performed with Qiagen's QIAprep Spin Miniprep Kit according 
to the manufacturer’s manual. To amplify plasmid DNA, One shot TOP10 or DH5 cells were 
transformed with the appropriate vector (see 3.2.2.) and 5 mL o/n cultures were set up with a 
single colony. 
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3.3.2 Determination of DNA concentration 
 
Concentration of DNA in solution was determined spectrophotometrically using Nanodrop 
1000 based on the absorbance at 260 nm. 
 
3.3.3. Polymerase chain reaction (PCR)  
 
PCR was used for DNA amplification. The proofreading high-fidelity DNA polymerase 
Phusion from Pyrococcus was used for amplification of DNA fragments for cloning strategies 
because of their low error rate. For colony-PCRs, the non-proofreading Taq DNA polymerase 
from Thermus aquaticus was used. Standard PCR reactions contained the components listed in 
Table 14. Annealing temperatures and elongation times were adjusted to primer and template 
composition and the size of the amplified fragment (Table 15). 
 
Table 14. Composition of PCR reactions. 
 
Component Cloning PCR (Phusion) Cloning PCR (Taq) 
Template DNA (25 ng) 1 µL 1 µL 
5' Primer (10 μmol L1) 1 µL 0.25 µL 
3' Primer (10 μmol L1) 1 µL  
dNTPs (10 mmol L1) 0.4 µL 0.65 µL 
Phusion DNA polymerase 
(2U*/ µL) 
0.2 µL  
5x Phusion HF buffer with 
MgCl2 
4 µL  
Taq  polymerase (5U / µL)  0.25 µL 
10x Taq reaction buffer 
MgCl2 (25 mmol L
1) 
 
2.5 µL 
1.5 µL 
Nuclease free H2O  12.4 µL 18.85 µL 
Final volume of: 20 µL 25 µL 
* One unit is defined as the amount of enzyme that will incorporate 10 nmol of dNTP into acid insoluble 
material in 30 minutes at 74 °C. 
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Table 15. Thermal cycling profile for cloning and colony PCRs. 
 
Component Cloning PCR (Phusion) Cloning PCR (Taq) 
Initial dentauration 30 s / 98 °C 2 min / 94 °C 
Denaturation 5-10 s / 98 °C 15 s / 94 °C 
Annealing               35 cycles 10-30 s / primer specific 
temperature 
15 s / primer specific 
temperature 
Extension 15-30 s per kb / 72 °C 1 min per kb / 72 °C 
Final extension 5-10 min / 72 °C 5-10 min / 72 °C 
 
 
3.3.4. Agarose gel electrophoresis 
 
DNA samples from PCR reactions were analyzed by agarose gel electrophoresis. Samples were 
loaded into wells of an agarose gel and subjected to an electric field, causing the negatively 
charged nucleic acids to move toward the positive electrode. Shorter DNA fragments traveled 
more rapidly, while the longest fragments remain closest to the origin of the gel, resulting in 
separation based on size. Supercoiled circular plasmid migrates more rapidly than the same 
plasmid when linearized whereas the nicked circular plasmid is the slowest in migration in 
comparison to the other two forms. Agarose gels (1 %, w/v) were prepared with TAE (40 mmol 
L1  Tris-base, 20 mmol L1 acetic acid, 1 mmol L1 EDTA pH = 8) buffer and with an addition 
of 50 μg L1 ethidium bromide. All samples were mixed with DNA loading dye (0.25 % (w/v) 
bromophenol blue, 0.25 % (w/v) xylene cyanol FF, 0.01 mol L1 EDTA pH = 8, 3 % (w/v) 
glycerol) prior to loading. Two different dyes are present for visual tracking of DNA migration 
during electrophoresis. The presence of glycerol ensures that the DNA in the ladder and sample 
forms a layer at the bottom of the well. The EDTA included in the solution binds divalent metal 
ions and inhibits metal-dependent nucleases. 1 kb DNA ladder (NEB) was applied for size 
estimation of DNA fragments. Electrophoresis was carried out at a constant voltage of 120 V. 
Afterwards DNA bands were visualized by UV transillumination at 254 nm and documented 
with the MiniBIS Imaging systems (DNR, Bio-Imaging Systems Ltd.). Ethidium bromide is a 
fluorescent dye that intercalates between bases of nucleic acids and allows detection of DNA 
fragments in gels. Ethidium bromide possesses UV absorbance maxima at 300 and 360 nm. 
Additionally, it can absorb energy from nucleotides excited by absorbance of 260 nm radiation. 
Ethidium re-emits this energy as yellow/orange light centered at 590 nm.99  
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3.3.5. Cloning and sequencing 
 
3.3.5.1. Standard cloning: restriction and ligation of DNA 
 
pGEX-6P-1 vector was linearized with restriction endonucleases BamHI and XhoI. The gene 
of interest (HP1326) was amplified (see 3.3.3) using primers (see 3.1.9.) that introduced an N-
terminal BamHI recognition site and a C-terminal XhoI site to allow directed integration into 
the vector.  
In the ligation reaction (Table 16) the vector was mixed with the gene of the insert and incubated 
together with T4-DNA ligase for 2 hours at 22 C. The reaction was quenched by letting the 
reaction mixture at 65 C for 10 min. After transformation of the cloned gene into DH5 cells 
the colonies were tested for successful integration of the insert by colony PCR. DNA from 
positive clones was amplified and isolated according to section 3.3.1 and sequenced at the 
DNA-servis center Macrogen Inc. using universal T7 primers (T7 for: 5' 
TAATACGACTCACTATAG GG 3', T7 rev: 5' GCTAGTTATTGCTCAGCGG 3'). 
 
Table 16. Ligation reaction mixture. 
 
Component V / µL 
Digested pGEX (100 ng) 5 
HP1326 gene (44 ng) 1 
T4 ligase (5 U* / µL) 0.5 
10 x T4 ligase buffer 1 
Nuclease free H2O 2.5 
Final volume: 10 
* One unit is defined as the amount of enzyme required to give 50 % ligation of HindIII fragments of λ DNA (5´ 
DNA termini concentration of 0.12 µmol L1, 300- µg/mL) in a total reaction volume of 20 μL in 30 minutes at 16 
°C in 1X T4 DNA Ligase Reaction Buffer. 
 
Cloning of HP1026 gene in vector pET15b was done in a collaboration with Dr. A. Danielli 
and Prof. V. Scarlato from the Department of Biology, Bologna, Italy.  
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3.3.5.2. Enzyme free-cloning 
 
1 µL of pre-processed linearized pETite C-His vector (25 ng) was mixed with 3 µL of the target 
PCR product (50 ng of HP1326 / HP0907, see 3.1.10.) and transformed directly into 50 µL of 
chemically competent One shot TOP10 cells (see 3.2.2.). The target gene had been previously 
amplified with primers that contained short homology to the ends of the pETite C-His vector 
allowing recombination within the host cell to fuse the blunt PCR product to the vector (Fig. 
12) Sequencing of DNA from positive clones was performed like previously described in 
section 3.3.5.1. 
 
 
Figure 12. Preparation of construct by enzyme free-cloning.100 
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3.4. Protein biochemical methods 
 
Experiments handling preparation and isolation of proteins were performed according to the 
instructions from the laboratory handbook J. Sambrook and D. Russell: Molecular Cloning: A 
Laboratory Manual, 3th edition, Cold Spring Harbor Laboratory Press (2001),98 or according to 
the datasheet instructions of the specific chemical/ kit that was used. 
 
3.4.1. Protein quantification 
 
The concentration of pure protein solutions was determined spectrophotometrically by reading 
absorption at 280 nm due to the high absorbance of aromatic amino acid residues. Considering 
absorbance and the protein specific absorption coefficient that was calculated on the basis of 
the primary sequence using ExPASy's ProtParam software,101 the protein concentration was 
determined by applying the Beer-Lambert law.  
 
3.4.2. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
The quality of the purified proteins samples, samples from expression studies, and protein 
crystals was verified by discontinuous electrophoresis under denaturing conditions (SDS-
PAGE). SDS is an anionic detergent which denatures proteins and confers a negative charge to 
all protein molecules, since a polypeptide chain binds an amount of SDS proportional to its 
molecular mass. The final separation of proteins depends entirely on the differences in the 
relative molecular mass of the polypeptides, so that in the electric field the negatively charged 
molecules will migrate toward the positively charged anode. For the experiments in this study 
the used percentage (w/v) of stacking and separating acrylamide gels was 4 % and 16 %, 
respectively (Table 17). Prior to use, all samples were supplied with 4x loading buffer (Table 
18) and incubated at 100 C (to improve denaturation) for 2 min in the case of pure proteins 
and for 10 min for the samples from expression studies. 
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Table 17. Composition of the stacking and separating acrylamide gels. 
 
Component Stacking gel Separating gel 
Acrylamide/bis-acrylamide (29:1 w/v) 40 %, (v/v) 4 % 16 % 
Buffer Tris-HCl, pH 6.8  0.125 mol L1  
Buffer Tris-HCl, pH 8.8  0.375 mol L1 
SDS, (w/v) 0.1 % 0.1 % 
APS 0.7 μg mL1 0.7 μg mL1 
TEMED, (w/v) 0.05 % 0.05 % 
 
Table 18. Composition of the 4x loading buffer. 
 
Tris-HCl pH = 6.8 62.5 mmol L1 
β-Mercaptoethanol 12.5 mmol L1 
Glycerol, (v/v) 6.25 %  
SDS, (w/v) 1.25 % 
Bromophenol Blue, (w/v) 0,002 %  
 
Different types of protein markers were used depending on the application. Unstained Bio-
Rad’s Precision Plus Protein Standard was used when gels were stained using the Coomassie 
Brilliant Blue R-250 solution (Table 19) or by using the commercial ProteoSilver Silver Stain 
Kit for silver staining. When western blotting was performed after electrophoresis, pre-stained 
Bio-Rad’s Precision Plus Protein Standard was used. SDS-PAGE was carried out at constant 
current (30-50 mA) and maximum voltage (600 V) within 12 h. Composition of the buffer 
used during electrophoresis is presented in Table 20. Gels stained by the Coomassie solution 
were de-stained with hot water. 
 
Table 19. Composition of the Coomassie Brilliant Blue R-250 staining solution.  
 
Coomassie Brilliant Blue R-250 2.5 g L1 
Acetic acid, (v/v) 10 % 
Ethanol, (v/v) 45 % 
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Table 20. Composition of the electrophoresis buffer. 
 
Buffer Tris-HCl, pH 8.3 3.03 g L1 
Glycin 14.4 g L1 
SDS, (w/v) 0.1 % 
 
Silver staining is a very sensitive method to detect very low amounts of protein in a SDS-PAGE 
gel with a detection limit of 0.1 ng.102 In this study the silver staining method was used to verify 
samples of protein crystals. After electrophoresis, the gel was incubated in fixation solution (50 
% (v/v) ethanol, 10 % (v/v) acetic acid) for 20 min, and then washed with ethanol (30 %, v/v) 
for 10 min, and then with ultrapure water for additional 10 min. Afterwards the gel was treated 
with a sensitizer solution (1 %, v/v ProteoSilver Sensitizer) for another 10 min, and then washed 
twice for 10 min with ultrapure water. Silver solution (1 %, v/v ProteoSilver Silver Solution) 
was applied for 10 min followed with washing for 1 min with ultrapure water. The staining 
process (the reduction of silver ions) was initiated by addition of the developing solution (5 %, 
v/v ProteoSilver Developer 1, 0.1 %, v/v ProteoSilver Developer 2) for 5 min, and was 
terminated by addition of ProteoSilver Stop solution for 5 min, and then washed with ultrapure 
water for 15 min. All used commercial solutions (ProteoSilver Silver Solution, ProteoSilver 
Sensitizer, ProteoSilver Developer 1, ProteoSilver Developer 2, ProteoSilver Stop Solution) are 
part of the ProteoSilver Plus Silver Stain Kit (Sigma Aldrich). 
 
3.4.3. Western blotting 
 
The western blotting method includes transfer of proteins from a gel to a membrane and their 
detection on the surface of the membrane by antibodies. In this work it was used to detect 
presence of His-tagged proteins. After SDS-PAGE, the separated protein samples were 
transferred from the acrylamide gels to the polyvinylidene fluoride (PVDF) membrane by the 
semi-dry western blotting method using the instrument 2117 Multiphor II (LKB). Before 
transferring, the gels were incubated with shaking in the transfer buffer (Table 21) for 15 min. 
All membranes and blotting papers were wetted in the transfer buffer, and the blot sandwich 
was assembled as follows: three sheets of paper, the transfer membrane, the gel and finally three 
more sheets of blotting paper were placed inside a semi-dry electro-blotting system with the 
membrane facing the anode. Protein transfer was performed at a constant current of 1 mA/cm2 
for 1.5 hours. After blotting, the protein transfer was confirmed by staining with the Ponceau S 
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(0.1 % (w/v), 5 % (v/v) acetic acid) solution. Afterwards transfer membranes were further 
analyzed by immunodetection. At first, membranes were washed with ultrapure water and 
incubated with 1 % (w/v) casein-TBS solution (Table 21) to saturate free binding sites of the 
membrane. After 60 min of incubation, membranes were washed three times with TBS buffer; 
each step lasting 10 min. Primary antibody (see 3.1.9.) was diluted 1,000 times in a 1 % casein-
TBS solution and was applied to the membrane o/n at 4 °C. Membranes were washed again 
three times for 10 min with the TBS buffer. The second antibody (see 3.1.9.) was diluted 10,000 
times also in the 1 % casein-TBS solution and applied to the membrane for 60 min. Then, 
washing with TBS buffer was repeated as before. The bound secondary antibodies were 
detected via the linked enzyme horseradish peroxidase using Immun-Star WesternC 
chemiluminescent kit (Bio-Rad Laboratories). The secondary antibody contains horseradish 
peroxidase, which is an enzyme that catalyzes luminol oxidation in the presence of hydrogen 
peroxide. The reaction forms an excited state of the substrate that emits light as it decays to the 
ground state. Luminescent signals derived from the oxidation of luminol were detected and 
quantified with the luminescent image analyzer Molecular Imaginig system (Carestream 
Health, Inc.). 
 
Table 21. List and composition of buffers used in western blotting. 
 
Transfer buffer 14.4 g L1 glycin, 3 g L1 Tris-HCl pH = 7.5, 20 % (v/v) ethanol 
TBS buffer 25 mmol L1 Tris-HCl pH = 7.5, 150 mmol L1 NaCl, 0.2 % (v/v) Tween 
 
3.4.4. Proteolytic cleavage 
 
3.4.4.1. Removal of the hexa His-tag from HP1026 with thrombin 
 
Purified His-tagged HP1026 protein was incubated with thrombin (0.1 U / µL) in a protein-
protease ratio 1:100, and buffer containing 20 mmol L1 Tris-HCl pH 7.5, 150 mmol L1 NaCl. 
The reaction mixture was incubated o/n at 4 C and gently shaked. The cleaved and uncleaved 
HP1026 were separated by running the whole mixture through nickel nitrilotriacetic acid (Ni-
NTA) column (see 3.6.1.2.) since the cleaved protein does not bind to the resin. Collected 
flowthrough was then passed through a benzamidine sepharose column (GE Healthcare) for 
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binding of residual thrombin and thus preventing secondary activity from this source. The yield 
of cleavage was monitored by SDS-PAGE and western blotting. 
 
3.4.4.2. Removal of the GST-tag from GST_HP1326 with PreScission protease 
 
Purified GST_HP1326 protein was treated with PreScission protease to cleave the N-terminal 
GST tag from the fusion protein. The protein:protease ratio was adjusted to 1:200 in a buffer 
containing 50 mmol L1 Tris-base pH 7.5, 50 mmol L1 NaCl, 1 mmol L1 EDTA, 1 mmol L1 
dithiothreitol (DTT). The sample was incubated at 4 °C on a shaker o/n. PreScission protease 
as well as uncleaved HP1326 contain the GST tag, so they were both removed from the cleaved 
sample by passing the sample through a glutathione agarose (GE Healthcare) column according 
to the manufacturer protocol (see 3.6.1.3.). 
 
3.4.4.3. Limited proteolysis of the FlgD (HP0907) protein 
 
Limited proteolysis of FlgD was also investigated. Protein regions exposed on the surface, 
either present in loops or in unstructured regions, are usually exposed to proteolytic cleavage, 
while the globular parts and stable secondary structure elements are not accessible to proteases. 
Each of the four samples of FlgD ( = 3 mg mL1) in 20 mmol L1 Tris-base pH 7.5, 150 mmol 
L1 NaCl was digested with selected proteases (trypsin,  chymotrypsin, thermolysin or 
thrombin) in 1:1000 and 1:500 ratios at 25 C and incubated for an hour. The yield of digestion 
was monitored by SDS-PAGE.  
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3.5. Expression of recombinant proteins in E. coli 
 
3.5.1. Expression of CrdA (HP1236), HP1026 and FlgD (HP0907) 
 
E. coli BL21(DE3) cells were chemically transformed with a desired plasmid (see Table 13 in 
3.1.10.). The used vectors contain either T7 (pET15b, pETite) or tac (pGEX-6P-1) promoters 
that are inducible by isopropyl-β-D-1-thiogalactopyranoside (IPTG) and are located upstream 
from the gene of interest. BL21(DE3) is the T7 host strain used for expression of cloned genes 
from the bacteriophage T7 promoter. The genome of bacteria harbors the T7 bacteriophage 
RNA polymerase gene under the control of the IPTG inducible lacUV5 promoter. The lac 
repressor protein is responsible for maintaining inducible control over the lacUV5 promoter as 
well as the T7-lac promoter on the vector.100 In case of protein toxicity BL21pLysS (DE3) cells 
were used for expression of toxic proteins since these cells provide tighter control of protein 
expression. BL21pLysS (DE3) cells contain pLysS that constitutively expresses low levels of 
T7 lysozyme, which reduces basal expression of recombinant genes by inhibiting basal levels 
of T7 RNA polymerase. 
LB medium was inoculated with a single colony from a freshly streaked plate and treated with 
the appropriate antibiotic for the plasmid and host strain and was shaked (180 rpm) at 37 C 
o/n. Fresh LB medium containing the appropriate antibiotic was inoculated with the overnight 
culture and incubated with shaking at 28 C or 16 C. In this work expression performed at 
different temperatures was tested to establish the best expression condition for different 
constructs. When the OD600 of 0.6 was reached, the protein expression was induced by adding 
0.5 mM IPTG. After induction of 4 h and o/n performed at 28 C and 16 C, respectively, cells 
were harvested by centrifugation (5000 rpm, 15 min, 4 °C) and flash-frozen in liquid nitrogen 
and stored at 80 °C. Afterwards, cells were thawed on ice, re-suspended in a protein specific 
buffer (Table 22), and disrupted with the One Shot Cell breakage system (Constant System Ltd., 
UK; 1.36 kbar). By standard, the cell suspension was passed through the system twice. Buffers 
used in cell disruption contain phenylmethylsulfonyl fluoride (PMSF) as a serine protease 
inhibitor. The lysate was later clarified by centrifugation (18 000 rpm, 30 min, 4 C) and the 
soluble fractions were used in further steps of purification. 
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Table 22. Composition of buffers used in cell disruption for a specific protein. 
 
CrdA GST_CrdA, HP1026, FlgD 
20 mmol L1 Tris-base pH 7.5 
200 mmol L1 NaCl 
0.05 % Triton X-100 
2 mmol L1 (PMSF) 
20 mmol L1 Tris-base pH 7.5 
150 mmol L1 NaCl  
2 mmol L1 PMSF 
 
3.5.2. Expression of selenomethionine- HP1026 and FlgD (HP0907) 
 
Expression of recombinant selenomethionine derivatized proteins was performed by using the 
non-methionine auxotrophic E. coli BL21 strain (DE3). The bacteria were grown in minimal 
medium M9 (Table 23) supplemented with vitamin B1, amino acids (L-leucine, L-isoleucine,  L-
valine, L-phenylalanine, L-lysine, L-threonine) and L-seleno-methionine103 at 28 C as described 
in section 3.5.1. All amino acids were purchased from Sigma Aldrich.  
Table 23. Composition of the M9 medium. 
Na2HPO4 6.78 g L1 
KH2PO4 3 g L1 
NaCl 0.5 g L1 
NH4Cl 5 g L1 
MgCl2 1 mmol L1 
CaCl2 0.1 mmol L1 
Trace elements* (v/v) 0.01 % 
D+ Glucose (w/v) 2 % 
* Trace elements: 0.1 g L1 MnSO4, 0.5 g L1 FeCl3, 8 mg L1 CuCl2, 0.05 g L1 ZnO, 10 mg L1 Co(NO3)2, 10 mg 
L1 (NH4)6Mo7O24, 5 g L1 EDTA 
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3.6. Purification of CrdA, HP1026 and FlgD 
 
Purity of samples during all steps of purification was monitored by the SDS-PAGE. 
 
3.6.1. Affinity chromatography 
 
3.6.1.1. Affinity chromatography using a Strep-Tactin 
 
Strep-tagged CrdA was purified by affinity chromatography using a strep-tactin resin. The 
Strep-tag (NH2-WSHPQFEK-COOH) purification system is based on the highly selective 
interaction between the Strep-tag fused to the protein and a specially engineered streptavidin 
called strep-tactin. The tagged protein binds to immobilized strep-tactin during affinity 
purification. Protein is eluted with a buffer containing desthiobiotin, which is the natural ligand 
of streptavidin (Fig. 13).104 
The strep-tactin resin (1 mL) was equilibrated with buffer A (Table 24), and the crude lysate 
was mixed with resin at  4 C o/n. Unbounded proteins were removed from the resin by washing 
the resin with 30 mL of buffer A. The Strep_CrdA protein was eluted from the resin by addition 
of 20 mL of buffer E (Table 24). Regeneration of the resin was performed by addition of yellow 
HABA (2-[4’-hydroxy-benzeneazo] benzoic acid) solution. HABA displaced desthiobiotin and 
turned the resin red due to the binding of HABA as a red colored hydrazine isomer to strep-
tactin and prior to the next purification it was removed from the resin by washing it with buffer 
A. 
 
Table 24. Composition of buffers used in affinity chromatography of StrepCrdA. 
 
Buffer A Buffer E 
20 mmol L1 Tris-base pH 7.5 
200 mmol L1 NaCl 
 
20 mmol L1 Tris-base pH 7.5 
200 mmol L1 NaCl 
5 mmol L1 desthiobiotin 
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Figure 13. Schematic presentation of affinity chromatography with strep-tactin.104 
 
3.6.1.2. Affinity chromatography with Ni-NTA agarose 
 
Purification of polyhistidine affinity-tagged proteins can be facilitated by utilization of the 
nickel-nitrilotriacetic acid resin. The nitrilotriacetic acid chelator linked to agarose binds His-
tagged proteins (5-10 mg His-tag protein / Ni-NTA resin mL) since the nitrogen atoms of the 
imidazole ring inside the His-tag have affinity toward the nickel ion and occupy two out of six 
nickel coordination sites (Fig. 14). 
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Figure 14. Ni-NTA chelating (a) two water moleules, or (b) two histidines.105 
 
In this study the Ni-NTA affinity purification of proteins (CrdA, HP1026, FlgD) containing the 
His6-tag was performed using the 1 mL columns. The column was firstly equilibrated with 
protein specific buffer A (Table 25) and then the soluble part of lysate was added to the column. 
To obtain a high purity sample, the column was connected to an ÄKTA Purifier system, and a 
washing step of 50 mL of buffer A supplemented with 20 mmol L1 imidazole was performed 
to eliminate unspecifically bound proteins. Finally, elution of the protein was performed in 
buffer A with a stepwise gradient of imidazole from 20 to 500 mmol L1.  
 
Table 25. Composition of buffer A used in Ni-NTA affinity chromatography of CrdA_His, 
FlgD_His and His_HP1026. 
 
CrdA_His FlgD_His, His_HP1026 
20 mmol L1 Tris-base pH 7.5 
200 mmol L1 NaCl 
20 mmol L1 Tris-base pH 7.5  
150 mmol L1 NaCl 
 
3.6.1.3. Affinity chromatography with gluthatione sepharose 
 
GST-fused proteins were purified using a gluthatione sepharose resin. Glutathione S-transferase 
(GST) is an enzyme found in most organisms and can make the tagged protein more soluble. 
The purification method is based on the high affinity of GST for glutathione (binding capacity 
is > 5 mg GST/mL chromatography medium). When applied to the affinity medium, GST-
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tagged proteins bind to the glutathione ligand, and impurities are removed by washing with 
binding buffer. Tagged proteins are then eluted from the chromatography medium using a 
buffer containing reduced gluthatione (Fig. 15). 
In this work GST_CrdA was purified using a gluthatione sepharose 1 mL column that was 
firstly washed with buffer A (Table 26), followed by the incubation of resin with a GST-tagged 
protein for 1 h at 4 C. Afterwards, the column was washed with 10 mL of buffer A and protein 
elution was performed using the buffer E (Table 26). 
 
Figure 15. Principle of GST-tag protein purification.106 
 
Table 26. Composition of buffers used in affinity chromatography of GST_CrdA. 
 
Buffer A Buffer E 
140 mmol L1 NaCl 
 2.7 mmol L1 KCl 
 10 mmol L1 Na2HPO4 
 1.8 mmol L1 KH2PO4 pH = 7.5 
10 mmol L1 reduced gluthatione 
 50 mmol L1 Tris-HCl pH = 8.0 
 
3.6.2. Size-exclusion chromatography (SEC) 
 
Analytical size-exclusion chromatography was used to separate proteins according to the 
different size and to determine homogeneity of a protein sample. In this study the used columns 
were Superdex75 10/300 and Superdex200 10/300 for the separation of proteins in the range Mr 
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= 3,000-70,000 and Mr =10,000-600,000, respectively (GE Healthcare). Prior to use, the 
column was equilibrated at a flow rate of 0.5-1 mL/min with 1.52 column volume (CV) of the 
appropriate buffer (Table 27). Fractions containing the pure protein were pooled and 
concentrated for crystallization purpose or other structural characterization assays.  
To estimate the oligomeric state of protein, calibration SEC was carried out with protein 
molecular mass standards: vitamin B12 (1.35 kDa), myoglobin (17 kDa), ovalbumin (44 kDa) 
and  globulin (158 kDa), and the void volume was determined by using Blue Dextran (GE 
Healthcare). 
 
Table 27. Composition of buffers used for SEC. 
 
CrdA FlgD HP1026 
20 mmol L1 Tris-base pH 7.5 
200 mmol L1 NaCl 
20 mmol L1 Tris-base 
pH 7.5  
150 mmol L1 NaCl 
20 mmol L1 Tris-base pH 7.5  
150 mmol L1 NaCl 
 
20 mmol L1 Tris-base pH 7.5 
200 mmol L1 NaCl 
0.5 mmol L1 Cu(OOCCH3)2 
20 mmol L1 Tris-base pH 7.5 
120 mmol L1 NaCl 
30 mmol L1 KCl 
1 mmol L1 MgCl2 
 
3.6.3. Ultrafiltration 
 
Ultrafiltration was used to concentrate dilute protein solutions or for buffer exchange. Amicon 
Ultra centrifugal filters were used with a molecular weight cut-off of 3 kDa (for CrdA), 10 kDa 
(for GST_CrdA) and 30 kDa (for HP1026, FlgD). This system uses anisotropic semi-permeable 
membranes to separate macromolecular species and solvents primarily on the basis of size. The 
filtrate (flow-through) is cleared of macromolecules which are significantly larger than the 
membrane pores. Desired protein solution was transformed to the adequate filter and 
centrifugation at 4000 rpm at 4 C was performed. Molecules smaller than the size of membrane 
pores were passed through the membrane while the concentration of protein solution increased. 
 
3.7. Refolding of the CrdA protein solubilized from inclusion bodies 
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After the cell disruption (4 g of fresh cells), lysate-containing CrdA was centrifuged at 18,000 
rpm for 30 min at 4 C to form a solid pellet. The pellet was solubilized by addition of 15 mL 
of denaturation buffer (6 mol L1 guanidinium chloride, 25 mmol L1 Hepes pH 7.9, 0.1 mmol 
L1 DTT, 0.2 mmol L1 PMSF) and shaked at 20 °C o/n. The sample was then centrifuged at 
22,000 rpm and 4 °C for 30 min. The pellet was resuspended in 15 mL of ultrapure water while 
the supernatant was collected and renaturation by dilution of CrdA was performed. The 
denatured proteins were diluted hundred to thousand fold with a refolding buffer that did not 
contain denaturants. In the dilution method, the protein concentrations are also decreased, thus 
preventing intermolecular aggregation of protein during the procedure.107 A set of 7 buffers was 
prepared to test for optimal refolding conditions (Table 28). Refolding buffers R1 to R7 (1.5 
mL) were transferred to 2 mL reaction tubes and 100 μL of denatured supernatant were added 
by slow dilution and incubated for 10 min at room temperature. Afterwards, samples were 
centrifuged for 15 min at 14,000 rpm at 4 °C and the supernatant was purified by affinity 
chromatography (see 3.6.1.1. and 3.6.1.2.). Samples from the elution, washing fractions and 
pellet fraction after denaturation (15 μl) were supplied with 4x loading buffer and analyzed by 
SDS-PAGE according to 3.4.2. The success of refolding treatment was evaluated by circular 
dichroism and 1D-NMR spectroscopy. 
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Table 28. Composition of re-naturation buffers. 
 
Composition R1 R2 R3 R4 R5 R6 R7 
MES / mmol L1 
pH 6 
50  50 50      
TRIS / mmol L1 
pH 8 
   50 50 50 50  
NaCl / mmol L1 9.6  200  240  9.6  9.6  240  240  
KCl / mmol L1 50  50  10  0.4  0.4  10  10  
MgCl2 / mmol L
1 2  2   2  2   2  
CaCl2 /mmol L
1 2  2   2  2   2  
PEG 3350, w/v  0.05 %  0.05 %   0.05 % 0.05 % 
Triton X-100, v/v  0.5 % 0.5 % 0.5 %   0.5 % 
 
3.8. Protein characterization  
3.8.1. Circular dichroism 
Circular dichroism (CD) refers to the differential absorption of the left and right circularly 
polarized components of circularly polarized light (Fig. 16a). The CD instrument displays the 
dichroism at a given wavelength of radiation expressed as either the difference in absorbance 
of the two components or as the ellipticity in degrees. In biological systems the observed 
ellipticities are of the order of 10 millidegrees, so a careful attention should be paid for setting 
the experimental conditions to detect a meaningful information.108 The chiral arrangement of 
peptide bonds in different forms of regular secondary structure found in proteins exhibits 
distinct far-UV CD spectra (Fig. 16b). 
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Figure 16. (a) Principle of CD spectroscopy, (b) Far-UV CD spectra associated with various 
types of secondary structure components.109 
 
In this study, CD in the far-UV region (195260 nm) was used for secondary structure 
analysis of proteins and for confirmation of the folding state after the refolding treatment. Far-
UV CD spectra were recorded with a Jasco spectro-polarimeter in a quartz cuvette with a path 
length of 0.5 mm and a volume of 70 μL. All measurements were performed with water diluted 
protein samples (c = 0.1  0.5 mg mL1) at room temperature. All spectra were corrected for 
buffer absorption prior to analysis. Spectra were recorded with a step resolution of 1 nm and a 
bandwidth of 2 nm. The scan speed was set to 50 nm/min and 4 spectra were accumulated. 
Afterwards, using software CDNN110 for quantitative secondary structure estimation the 
observed data expressed as  (in milidegrees) were converted to  by the equation: 
 =   (MWR/  d)  100 
 - observed ellipticity in degrees 
MWR- the mean residue molar weight of the protein (molecular mass in Daltons / number of 
residues) 
 – protein concentration in mg mL1 
d – the optical path length in cm. 
CDNN is program which uses CD spectra of a set of proteins for which secondary and tertiary 
structures are known to be comparable to the CD spectra of the protein being studied. 
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3.8.2. One-dimensional NMR spectroscopy (1D NMR) 
1D-NMR was used as an additional technique for rough evaluation of the presence of secondary 
structure elements of the refolded sample of CrdA. This measurement was performed in 
collaboration with Prof. Massimo Bellanda (University of Padua, Department of Chemistry, 
Padua). 
 
3.8.3. Light scattering 
 
Dynamic and static light scattering techniques (DLS, SLS) are used in this work to investigate 
the size distribution, stability and aggregation state of protein molecules in solution. The main 
difference between DLS and SLS is that the DLS instrument measures at a fixed angle (90 to 
the incident laser light) and can only determine the mean particle size in a limited size range, 
while the multi-angle SLS instruments can determine the full particle size distribution. 
  
3.8.3.1. Dynamic light scattering (DLS) 
 
The basic principle in a dynamic light scattering experiment (also known as photon correlation 
spectroscopy or quasi-elastic light scattering) is that the sample is illuminated by a laser beam 
and the fluctuations of the scattered light are detected at a known scattering angle  by a fast 
photon detector (Fig. 17). Molecules in solution obey Brownian motion, which means that small 
molecules move faster than large ones.   
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Figure 17. Schematic representation of the optical setup of a DLS system.111 
 
The obtained information during the DLS analysis is about the time scale of the movement of 
the scatterers. The translational diffusion coefficient Dt is derived from these data using an auto-
correlation function. Since the hydrodynamic radius Rh is related to the DT of the particles Rh 
can be calculated using the Stokes-Einstein relation:  
Dt = kB T / 6   Rh, 
where kB is Boltzmann’s constant (1.381  1023 J K1) and  the dynamic viscosity of the 
solvent.112  
In this study, DLS measurements of proteins (Zetasizer Nano ZS, Malvern Instruments Ltd) 
were performed to examine the dispersity of samples at concentration of 510 mg mL1 at 298 
K. Prior to use samples were centrifuged for 10 min at 10,000 rpm, and 40 µL of supernatant 
was transferred into the quartz ZEN 2112 cuvette. 
 
3.8.3.2. Static light scattering (SLS) 
 
SLS is used to determine the weight average molecular weight Mw of a protein. Since the 
measurement of the scattering intensity is performed at different angles, it is possible to evaluate 
the root mean square radius of the macromolecules, also called the radius of gyration Rg. 
In order to examine the oligomeric state of the FlgD protein, the analytical size-exclusion 
chromatography of the diluted protein (1 mg mL1) in combination with multi angle light 
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scattering (MALS, Astra 6.1, miniDAWN TREOS) was carried out by using a Superdex 200 
10/300 GL (GE Healthcare) column equilibrated with buffer containing 20 mmol L1 Tris-base 
pH 7.5, 150 mmol L1 NaCl. This experiment was performed at the Division of Biochemistry, 
Faculty of Science, University of Zagreb. 
 
3.8.4. Thermofluor assay 
 
The influence of different additives, buffers and affinity tag on the protein stability was tested 
by fluorescence-based thermal stability assay. In this procedure a fluorescence dye interacts 
with exposed hydrophobic regions of the protein because of their partial or full unfolding upon 
heat denaturation. The obtained result is a sigmoidal curve that allows calculation of the melting 
temperature (Tm
i).113 
The thermofluor assay was performed in case of the HP1026 protein using a real-time PCR 
instrument (Applied Biosystems). Each well of  a 96-wells plate was filled with 44 µL of protein 
(1.7 µmol L1) solution, 2  µL of tested additive / buffer (Table 29 and 30) and 4 µL of  Sypro 
orange dye 62 (Invitrogen), and sealed with an optic view cover seal. The plate was then 
centrifuged at 4 C at 1000 rpm for 30 seconds immediately before the start of the assay to 
remove possible air bubbles. The measurement was set from 16 to 96 C with initial stepwise 
increments of 1 C. The wavelengths for excitation and emission were 490 and 575 nm, 
respectively. 
 
Table 29. Composition of the Additive screen (Hampton research) used in the thermofluor 
assay. 
1.    (A1)  0.1 mol L1 Barium chloride dihydrate 
2.    (A2) 0.1 mol L1  Cadmium chloride hydrate 
3.    (A3) 0.1 mol L1  Calcium chloride dihydrate 
4.    (A4) 0.1 mol L1  Cobalt(II) chloride hexahydrate 
5.    (A5) 0.1 mol L1  Copper(II) chloride dihydrate 
6.    (A6) 0.1 mol L1  Magnesium chloride hexahydrate 
7.    (A7) 0.1 mol L1  Manganese(II) chloride tetrahydrate  
                                                 
 
 
i Tm is a temeperature where the protein is 50 % unfolded. 
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8.    (A8) 0.1 mol L1  Strontium chloride hexahydrate 
9.    (A9) 0.1 mol L1  Yttrium(III) chloride hexahydrate 
10.   (A10) 0.1 mol L1  Zinc chloride 
11.    (A11) 0.1 mol L1  Iron(III) chloride hexahydrate 
12.   (A12) 0.1 mol L1  Nickel(II) chloride hexahydrate 
13.   (B1) 0.1 mol L1  Chromium(III) chloride hexahydrate 
14.   (B2) 0.1 mol L1  Praseodymium(III) acetate hydrate 
15.   (B3) 1.0 mol L1  Ammonium sulfate 
16.   (B4) 1.0 mol L1  Potassium chloride 
17.   (B5) 1.0 mol L1  Lithium chloride 
18.   (B6) 2.0 mol L1  Sodium chloride 
19.   (B7) 0.5 mol L1  Sodium fluoride 
20.  (B8) 1.0 mol L1  Sodium iodide 
21.   (B9) 2.0 mol L1  Sodium thiocyanate 
22.  (B10) 1.0 mol L1  Potassium sodium tartrate tetrahydrate 
23.  (B11) 1.0 mol L1  Sodium citrate tribasic dihydrate 
24.  (B12) 1.0 mol L1  Cesium chloride 
25.  (C1) 1.0 mol L1  Sodium malonate pH 7.0 
26.  (C2) 0.1 mol L1  L-Proline 
27.  (C3) 0.1 mol L1  Phenol 
28.  (C4) 30% v/v Dimethyl sulfoxide 
29.  (C5) 0.1 mol L1  Sodium bromide 
30.  (C6) 30% w/v 6-Aminohexanoic acid 
31.   (C7) 30% w/v 1,5-Diaminopentane dihydrochloride 
32.  (C8) 30% w/v 1,6-Diaminohexane 
33.  (C9) 30% w/v 1,8-Diaminooctane 
34.  (C10) 1.0 mol L1  Glycine 
35.  (C11) 0.3 mol L1  Glycyl-glycyl-glycine 
36.  (C12) 0.1 mol L1  Taurine 
37.  (D1) 0.1 mol L1  Betaine hydrochloride 
38.  (D2) 0.1 mol L1  Spermidine 
39.  (D3) 0.1 mol L1  Spermine tetrahydrochloride 
40.  (D4) 0.1 mol L1  Hexammine cobalt(III) chloride 
41.   (D5) 0.1 mol L1  Sarcosine 
42.  (D6) 0.1 mol L1  Trimethylamine hydrochloride 
43.  (D7) 1.0 mol L1  Guanidine hydrochloride 
44.  (D8) 0.1 mol L1  Urea 
45.  (D9) 0.1 mol L1  β-Nicotinamide adenine dinucleotide hydrate 
46.  (D10) 0.1 mol L1  Adenosine-5’-triphosphate disodium salt hydrate 
47.  (D11) 0.1 mol L1  TCEP hydrochloride 
48.  (D12) 0.01 mol L1  GSH (L-Glutathione reduced), 0.01 mol L1  GSSG (L-Glutathione oxidized) 
49.  (E1) 0.1 mol L1  Ethylenediaminetetraacetic acid disodium salt dihydrate 
50.  (E2) 5% w/v Polyvinylpyrrolidone K15 
51.   (E3) 30% w/v Dextran sulfate sodium salt 
52.  (E4) 40% v/v Pentaerythritol ethoxylate (3/4 EO/OH) 
53.  (E5) 10% w/v Polyethylene glycol 3,350 
54.  (E6) 30% w/v D-(+)-Glucose monohydrate 
55.  (E7) 30% w/v Sucrose 
56.  (E8) 30% w/v Xylitol 
57.  (E9) 30% w/v D -Sorbitol 
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58.  (E10) 12% w/v myo-Inositol 
59.  (E11) 30% w/v D -(+)-Trehalose dihydrate 
60.  (E12) 30% w/v D -(+)-Galactose 
61.   (F1) 30% v/v Ethylene glycol 
62.  (F2) 30% v/v Glycerol 
63.  (F3) 3.0 mol L1  NDSB-195 
64.  (F4) 2.0 mol L1  NDSB-201 
65.  (F5) 2.0 mol L1  NDSB-211 
66.  (F6) 2.0 mol L1  NDSB-221 
67.  (F7) 1.0 mol L1  NDSB-256 
68.  (F8) 0.15 mmol L1  CYMAL®-7 
69.  (F9) 20% w/v Benzamidine hydrochloride 
70.  (F10) 5% w/v n-Dodecyl-N,N-dimethylamine-N-oxide 
71.   (F11) 5% w/v n-Octyl-β- D -glucoside 
72.  (F12) 5% w/v n-Dodecyl-β- D -maltoside 
73.  (G1) 30% w/v Trimethylamine N-oxide dihydrate 
74.  (G2) 30% w/v 1,6-Hexanediol 
75.  (G3) 30% v/v (+/-)-2-Methyl-2,4-pentanediol 
76.  (G4) 50% v/v Polyethylene glycol 400 
77.  (G5) 50% v/v Jeffamine M-600 pH 7.0 
78.  (G6) 40% v/v 2,5-Hexanediol 
79.  (G7) 40% v/v (±)-1,3-Butanediol 
80.  (G8) 40% v/v Polypropylene glycol P 400 
81.   (G9) 30% v/v 1,4-Dioxane 
82.  (G10) 30% v/v Ethanol 
83.  (G11) 30% v/v 2-Propanol 
84.  (G12) 30% v/v Methanol 
85.  (H1) 10% v/v 1,2-Butanediol 
86.  (H2) 40% v/v tert-Butanol 
87.  (H3) 40% v/v 1,3-Propanediol 
88.  (H4) 40% v/v Acetonitrile 
89.  (H5) 40% v/v Formamide 
90.  (H6) 40% v/v 1-Propanol 
91.   (H7) 5% v/v Ethyl acetate 
92.  (H8) 40% v/v Acetone 
93.  (H9) 0.25% v/v Dichloromethane 
94.  (H10) 7% v/v 1-Butanol 
95.  (H11) 40% v/v 2,2,2-Trifluoroethanol 
96.  (H12) 40% v/v 1,1,1,3,3,3-Hexafluoro-2-propanol 
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Table 30. List of additives (not present in Additive screen) and buffers used in the thermofluor 
assay. 
500 µmol L1   Adenosine-5’-(-thio)-triphosphate tetralithium salt 
500 µmol L1   ADP Adenosine-5′-diphosphate sodium salt  
500 µmol L1   GTP Guanosine-5’-triphosphate sodium salt hydrate 
500 µmol L1   GDP Guanosine -5′-diphosphate sodium salt 
1 mol L1  MES pH 6.5 
1 mol L1  HEPES pH 7 
1 mol L1  TRIS pH 7.5 
1 mol L1  TRIS pH 8 
1 mol L1  TRIS pH 8.5 
1 mol L1  TRIS pH 8.8 
1 mol L1  TRIS pH 9.5  
 
3.8.5. Mass spectrometry 
Mass spectrometry was used to monitor the level of degradation of FlgD_26695 in solution and 
also the crystallized FlgD_26695. The sample from the crystal of the tetragonal form of 
FlgD_26695 was prepared by dissolving the crystal in the SDS-PAGE loading buffer. This 
sample together with full-length FlgD_26695 was checked by SDS-PAGE, and the bands 
obtained from the crystallized sample and full-length FlgD_26695 were isolated and in gel 
digested with trypsin. The fractions of the extracted peptides were dried out, dissolved in 50 % 
acetonitrile, supplemented with 0.1 % formic acid and directly injected in the nanoESI source. 
Mass measurements were performed with a quadrupoleTOF spectrometer (Waters, 
Manchester, UK) (capillary voltage: 2800 – 3000 V; cone voltage: 45 V; scan time: 1 s; 
interscan: 0.1 s). Analyses of the spectra were performed by using the MASSLYNX software 
(Micromass, Wynthenshow, UK). The mass of the FlgD_G27 monomer was determined by 
mass analysis of the peaks isolated by reverse phase chromatography (C4-column, RPHPLC). 
All mass experiments were performed in collaboration with Prof. P. Polverino de Laureto from 
the Department of Pharmaceutical Sciences, University of Padua. 
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3.8.6. ATPase activity assay by reversed-phase high-performance liquid chromatography (RP-
HPLC) 
 
ATPase activity of the HP1026 protein was tested by utilizing RP-HPLC with a detection limit 
of 0.05 nmol of ADP hydrolyzed from ATP. After termination of the ATPase reaction the 
product of enzymatic hydrolysis ADP and substrate ATP were separated by RP-HPLC. The 
amount of ADP was quantified from the chromatographic peak by measuring the absorbance 
of ADP at 259 nm.114 
To examine the activity of purified enzyme a master mix reaction (260 µL) was prepared at a 
concentration of 30 µmol L1 HP1026 in buffer containing 20 mmol L1  Tris-base pH 7.5, 150 
mmol L1 NaCl and 10 mmol L1 MgCl2 and incubated for 1 min at 30 C. Afterwards ATP was 
added in a concentration of 1 mmol L1. The reaction mixture was performed at 30 C and 40-
µL aliquots were taken in a time-dependent manner. The ATP hydrolysis reaction was 
quenched by incubation of the reaction mixture at 100 C for 2 min and centrifuged at 14,000 
rpm for 15 min. A 20-µL aliquot of the clear supernatant was applied to a RP-HPLC column 
(Synergi MAX-RP 80A, 150 × 4.6 mm, 4 μm; Phenomenex) equilibrated with the buffer of 50 
mmol L1 Na2HPO4 pH 6, 10 mmol L
1 tetra-n-butylammonium bromide and 4 % (v/v) 
acetonitrile at a flow rate of 0.8 mL/min. The tetra-n-butylammonium bromide was added to 
the buffer for separation of ADP and ATP that are hydrophilic molecules. The absorbance of 
ADP was monitored at 254.4 nm using a UV detector. Prior to running the reaction mixture, 
runs of pure ADP and ATP solutions (in water and in a buffer used in the activity assay) at a 
concentration of 1 mmol L1 was performed. The same experiment was performed only by 
changing the concentration of substrate ATP in an incubation time of 15 min at 30 C. The 
obtained results were evaluated using a nonlinear regression (applying Michaelis-Menten 
model, performed using GraphPad Prism)115 for the calculation of kinetic parameters (Km
ii, 
vmax
iii). 
 
  
                                                 
 
 
ii Km is the substrate concentration needed to achieve a half-maximum enzyme velocity. 
iii Vmax is the velocity of the enzyme extrapolated to very high concentrations of substrate. 
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3.8.7. Ultraviolet-visible (UV-VIS) titration 
 
UV-VIS titration was performed to investigate the affinity of the CrdA protein toward copper(II) 
ions. Before performing the titration experiment CrdA was incubated with 10 mmol L1  EDTA 
to remove any possibly bound metal ions, and then the buffer was exchanged to the buffer 
containing 30 mmol L1  Na2HPO4 pH 7 and 50 mmol L
1 NaCl. Copper titrations were 
performed on an Agilent 8453 UV-vis Spectroscopy System at room temperature in the 
wavelength range 200800 nm. 1mL of CrdA (150 µmol L1) was titrated with CuSO4 using a 
stock solution at a concentration of 10 mmol L1. All spectra were blanked against the used 
buffer. Reaction was incubated for 5 min after every new addition of titrant before measuring 
the absorbance. 
 
3.8.8. Crystallographic studies 
 
X-ray diffraction on a single crystal was used for the crystal structure determination. 
 
3.8.8.1. Crystallization 
 
The Solubility Tool Kit (Molecular Dimension) was used to get a more detailed information on 
the solubility profile of proteins and to determine the suitable concentration of proteins for 
crystallization trials. The strategy comprises testing solubility of proteins by changing the 
concentration and type of salt at constant pH values of 4.5 and 9.0. This allows initial solubility 
screening in salt solutions, since most proteins will carry a net positive and net negative charge 
at pH 4.5 and pH 9.0, respectively. Another approach includes testing the ability for crystal 
growth at a pH close to the pI in addition of organic precipitants, such as polyethylene glycols 
(PEGs) and MPD (2-methyl-2,4-pentanediol) at different ratios since ionic strength is poor at 
this pH value because the net charge of the protein is near zero. 
Initial crystallization trials were carried out with different 96-well screens from Qiagen or 
Molecular Dimensions. All initial screens were prepared by an Oryx 8 robot (Douglas 
Instruments) using the sitting drop vapor diffusion technique (Fig. 18a) in the MRC 96-well 
sitting drop plate (Molecular Dimensions). In this technique, water evaporates from the protein 
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containing droplet since the precipitant concentration is lower than in the reservoir. The system 
will equilibrate creating a supersaturated condition in the drop therefore increasing protein and 
precipitant concentrations and the chance of crystal growth.116 Each drop was prepared by 
mixing equal volumes of protein and precipitant solutions (500 nL), and equilibrated against 75 
µL of the mother liquid solution. Plates were sealed with Crystal Clear Sealing Tape from 
Hampton Research and stored at a temperature of choice (20 °C and / or 4 °C).  
 
Figure 18. Diffusion experiment setup for: (a) sitting drop, (b) hanging drop.116 
 
After the hit conditions containing crystals were obtained, they were optimized by varying the 
drop size, volume ratio between the precipitant and protein, and ratio of components of the 
precipitant solution. For the optimization purpose, the hanging drop vapor diffusion technique 
was also used in a 24-well XRL plates (Fig. 18b). Additionally, the influence of 96 different 
additives (Additive Screen) on the initial screening solution in a ratio 1:9 was explored. In case 
of the HP1026, protein microseeding was applied as well. Crystals obtained from a sitting drop 
experiment were transferred to a 1.5 mL reaction tube prepared with 50 μL of precipitant 
solution and a PTFE bead. The crystals were sonicated twice for one minute. This stock solution 
of seeds was used for further sitting drop trials in a set up with 1 μL drops and the final ratio of 
seeding solution of 10 % (v/v). 
Before the diffraction experiment, potential protein crystals were visualized by using the UV 
fluorescence microscope for differentiation of protein from salt crystals. Prior to data collection, 
crystals were directly cooled in liquid nitrogen or, if needed, frozen with a cryoprotectant. 
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Diffraction quality of crystals was tested at the ID14-4 beamline of the European Synchrotron 
Radiation Facility (ESRF, Grenoble, France) or at the PXIII beamline of the Swiss Synchrotron 
Light Source (SLS, Villigen, Switzerland). 
 
3.8.8.2. Data processing and structure determination 
 
Diffraction data of the native monoclinic form of FlgD (FlgD_m) were measured at the ID14-
4 beamline of the European Synchrotron Radiation Facility (ESRF, Grenoble, France). Crystals 
of both native and seleno-methionine tetragonal form of FlgD (FlgD_t) were measured at the 
PXIII beamline of the Swiss Synchrotron Light Source (SLS, Villigen, Switzerland). In case of 
SeMet_FlgD_t a fluorescence emission scan at the selenium edge was performed to optimize 
the energy for anomalous measurements. Diffraction data of FlgD_m and FlgD_t were indexed 
and integrated with software iMOSFLM117 and XDS118, respectively. All datasets were merged 
and scaled with Scala119, contained in the CCP4 crystallographic package.120 The tetragonal 
structure was solved by MAD data using the Shelx software.121 Initial phases were submitted 
to the Buccaneer software122 for density modifications and model building. The obtained model 
was used for refinement against the native data set at higher resolution with Phenix,123 and 
checked and manually adjusted with the graphic software Coot.124 The monoclinic form was 
solved by Molrep125 starting from the refined tetragonal structure as the template. During 
refinement of FlgD_m non-crystallographic symmetry restraints were imposed under the 
REFMAC5 program.126  
 
3.8.9. Bioinformatics methods and software tools 
 
Sequence similarity searches were performed with BLAST127 algorithm accessing databases 
UniProtKB128 and NCBI’s non-redundant protein sequence database. For multiple alignments 
of protein sequences ClustalW2129 or Clustal Omega130 were used. Translation of nucleotide 
sequences was performed with Translate. For computing physicochemical properties of a 
protein, the program ProtParam was used. Potential cleavage sites for proteases were identified 
with PeptideCutter. All last three programs are part of ExPASy’s101 proteomics tools. For the 
prediction of protein secondary structure elements, PSIPRED131 software was used. Prediction 
of signal peptides was done by using the LipoP132 software. Molecular graphics images of 
protein structures deposited at the protein database RCSB PDB (www.pdb.org)133 were 
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produced with the CCP4MG47 or Pymol134 software. PISA135 software was used to calculate 
crystal packing contacts. 
§ 3. Materials and Methods 64 
Ivana Kekez Doctoral Thesis 
§ 4. Results and Discussion 65 
Ivana Kekez Doctoral Thesis 
§ 4. RESULTS AND DISCUSSION 
4.1. FlgD protein from H. pylori (HpFlgD) 
 
4.1.1. Cloning, expression and purification 
 
The HP0907 gene was cloned from two different H. pylori strains, 26695 and G27. Cloning 
from different strains was performed since the HpFlgD sequence analysis by the PSIPRED 
bionformatic tool (http://bioinf.cs.ucl.ac.uk/psipred/) predicted 15 extra disordered amino acids 
(Pro273 to Lys287) of the protein from strain G27 in respect to strain 26695 (Fig. 19). This 
approach was used to gain a more successful crystallization outcome. 
Recombinant HpFlgD was successfully expressed and purified to homogeneity by Ni-NTA 
chromatography and size-exclusion chromatography (Fig. 20). Purified native HpFlgD_26695 
and HpFlgD_G27 were concentrated to 17.5 mg mL1 and 30 mg mL1, respectively, and used 
in the crystallization experiment.  
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Figure 19. Sequence alignment of HpFlgD_26695 (HP, O25565_HELPY), HpFlgD_G27 (HP, 
B5Z7R3_HELPG), PaFlgD (PA, Q9I4Q0_PSEAE) and XcFlgD (XC, Q8P9B5_XANCP) 
using CLUSTAL W2.129 The alignment figure was generated using ESPript 3.136 The 
numbering system is based on the HpFlgD_26695 sequence. Residues conserved in all four 
sequences are labelled in white and highlighted in red, while similar residues are labelled in 
red. Labels of the secondary structure elements ( sheets) found in the crystal structure of 
HpFlgD_t are presented in light blue (Fn-III domain) and dark blue (tudor domain) while the 
starting and ending residue found in the crystal structure of HpFlgD_t is marked with a green 
arrow. 
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Figure 20. (a) SDSPAGE; Lane 1  full-length HpFlgD_26695. (b) Analytical gel filtration 
chromatogram of HpFlgD_26695 (purple curve; molecular mass of the monomer 34.5 kDa) 
which elutes as a single peak at the volume of 13.82 mL corresponding to the molecular mass 
of 77.19 kDa.  
 
4.1.2. Crystallization and data collection 
 
Good quality crystals were grown by the sitting drop vapor diffusion technique. 1 l drops were 
prepared by mixing the protein and precipitant solutions in a ratio 1:1, and equilibrated against 
75 l of the mother liquor in the reservoir. Two different crystal forms were obtained after 
approximately 2 months (Fig. 21). Monoclinic crystals of HpFlgD_G27 (HpFlgD_m) were 
grown from the screening solution 4 of the PACT suite (Qiagen) (0.1 mol L1 SPG pH 7.0, 25 
% PEG 1500) at 20 C, while tetragonal crystals (HpFlgD_t) of the construct HpFlgD_26695 
were obtained from the screening solution 79 of the same screening kit (0.2 mol L1 sodium 
acetate, 0.1 mol L1 Bis-tris propane pH 7.5, 20 % PEG 3350) at 4 C. In order to solve the 
phase problem, seleno-methionine derivatized HpFlgD_26695 was crystallized (concentration 
of 15 mg mL1) at 277 K from solution 4 of the PACT suite. Monoclinic crystals were directly 
cooled in liquid nitrogen, whilst the tetragonal crystals were cryoprotected by using the 
precipitant solution supplemented with 20 % of ethylene glycol.  
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Figure 21. (a) Monoclinic crystal of native HpFlgD_G27 and (b, c) tetragonal crystal of native 
HpFlgD_26695. Picture (b) was captured under the microscope using a fluorescence excitation 
filter (CWL / BW = 500 / 50 nm). 
 
Diffraction data of native HpFlgD_m were measured at the ID14-4 beamline of the 
European Synchrotron Radiation Facility (ESRF, Grenoble, France) and they belong to the P2 
space group (Table 31). Crystals of both native and seleno-methionine HpFlgD_t belong to the 
tetragonal space group I422 (Table 31). Diffraction data of this second crystal form were 
measured at the PXIII beamline of the Swiss Synchrotron Light Source (SLS, Villigen, 
Switzerland). A fluorescence emission scan at the selenium edge was performed to optimize 
the energy for anomalous measurements. Diffraction data of HpFlgD_m and HpFlgD_t were 
indexed and integrated with software iMOSFLM117 and XDS,118 respectively. All datasets were 
merged and scaled with Scala119, contained in the CCP4 crystallographic package.120 Molecular 
replacement was attempted by using different models that were built upon the template 
structures of the orthologues from other species. This method failed due to significant 
differences in the overall structure. The tetragonal structure was solved by MAD data using the 
Shelx software.121 Initial phases were submitted to the Buccaneer software122 for density 
modifications and model building. The obtained model was used for refinement against the 
native data set at higher resolution (2.17 Å) with Phenix123, and checked as well as manually 
adjusted with the graphic software Coot124. The monoclinic form was solved by Molrep125 
starting from the refined tetragonal structure as the template. During refinement of HpFlgD_m 
non-crystallographic symmetry restraints were imposed under the REFMAC5 program.126 The 
final statistics on data collection and refinement are summarized in Tables 31 and 32. 
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Table 31. Statistics of data collection and processing. Values for the outer shell are given in 
parentheses. 1800 frames of 0.1° were collected. One crystal was used to collect diffraction 
data for MAD anomalous phasing. 
 Native  HpFlgD_m MAD data SeMet_HpFlgD_t Native  HpFlgD_t 
  Peak Inflection Remote  
Crystal system Monoclinic  Tetragonal  Tetragonal 
Space group P2  I422  I422 
Wavelength / Å 0.95372 0.97939 0.97957 0.97171 0.99988 
Unit cell parameters / Å,  
 
 
 
 
a = 77.42 
b =34.22 
c =131.64 
 = 99.6 
a = 76.42 
c = 144.98 
 
 
a = 76.49 
c = 145.05 
 
 
a = 76.47 
c = 145.03 
 
 
a = 76.42 
c = 145.43 
 
 
Z  
unit cell 8 16 16 16 16 
asymmetric unit 4 1      1 1 1 
Resolution range / Å 
54.09  2.75 
(2.88  2.75) 
43.33 – 2.78 
(2.9  2.78) 
43.36 – 2.74 
(2.89  2.74) 
43.35 – 2.73 
(2.88  2.73) 
43.37  2.17 
(2.28  2.17) 
Rmerge 0.077 (0.551) 0.099 (1.376) 0.112 (2.154) 0.100 (1.590) 0.059 (0.666) 
Rpim 0.047 (0.345) 0.047 (0.586) 0.047 (0.955) 0.045 (0.715) 0.025 (0.332) 
<I /σ(I)> 14.4 (2.8) 15.1 (1.4) 14.5 (0.8) 15.5 (1.0) 20.5 (2.1) 
CC half 0.991 (0.742) 0.998 (0.658) 0.998 (0.489) 0.998 (0.465) 0.999 (0.746) 
Completeness / % 99.9 (99.5) 96.4 (78.6) 95.6 (72.7) 94.9 (68.2) 98.5 (90.0) 
Anomalous Completeness / %  95.3 (72.3) 94.0 (62.2) 93.3 (58.6)  
Redundancy 3.6 (3.5) 6.9 (6.0) 6.9 (5.3) 6.9 (5.1) 6.9 (5.5) 
Unique reflections 18375 (1808) 5489 (632) 5675 (596) 5704 (573) 11714 (1019) 
 
Table 32. Refinement statistics. 
 Native  HpFlgD_m Native  HpFlgD_t 
Rwork / Rfree 0.221/0.275 0.197/0.234 
No. protein / solvent atoms 4628/44 1156/74 
Mean B (Å2) 62.1 50.5 
R.m.s.d. from ideal value   
Bond length (Å) 0.011 0.008 
Bond angles (°) 1.49 1.11 
Geometry   
Ramachandran favored (%) 97.0 95.14 
Ramachandran outliers (%) 0 0 
Rotamer outliers (%) 1.8 0 
Overall score 
 
1.32 1.70 
 
 
4.1.3. Size of HpFlgD in solution 
 
Recombinant His tagged HpFlgD_26695 was eluted as single peak, at a volume of 13.82 mL 
(Fig. 20b). The molecular mass calculated from the analytical size-exclusion chromatography 
analysis was about 77.2 kDa for the His tagged HpFlgD that was in agreement with the size of 
protein estimated by MALS measurement (MW HpFlgD_26695_His6 = 78.7 kDa). Considering 
that the HpFlgD_26695 monomer is a His tag fusion protein (2.7 kDa), its molecular mass is 
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approx. 34.5 kDa and therefore, the HpFlgD oligomerization state is likely to be dimeric in the 
solution.  
CD analysis was used to confirm the folded state of the recombinant samples as well as to 
evaluate the overall secondary structure content. According to the CD analysis, full-length 
HpFlgD_G27 is mainly composed of -sheets and random coils. The presence of -helices was 
also detected but with a minor contribution (Fig. 22 and Table 33). 
 
Figure 22. CD spectrum of the full-length HpFlgD_G27 in the far UV region (190260 nm) 
presented as a CD signal in milidegrees. 
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Table 33. CD data of the full-length HpFlgD_G27 analyzed by the secondary structure analysis 
software, CDNN.110 Deconvoluted results are shown as contributions of the various 
components to the protein secondary structure. 
SECONDARY STRUCTURE 
ELEMENT 
% 
Helix 12.8 
Antiparallel  sheet 25.2 
Parallel  sheet 5.0 
 turn 22.8 
Random coil 24.8 
 
Results of the western blotting (Fig. 23) confirmed presence of a His tag at the C-terminus 
in the full-length HpFlgD while the crystallized fragment is lacking the signal for the anti His 
antibodies. 
 
 
Figure 23. (a) SDSPAGE; (b) Western blot against His tag at the C-terminal end. Lane 1  
full-length HpFlgD_26695 (top band) with initial degradation products (lower bands), Lane 2 
– dissolved crystal of HpFlgD_t. 
 
4.1.4. Size of HpFlgD in the crystal  
 
Crystallization of the full-length proteins of both strains, HpFlgD_G27 and HpFlgD_26695, 
was attempted as was demonstrated by SDS – PAGE electrophoresis that confirmed that full-
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length protein was present in the sample used to set up crystallization experiments (Fig. 20a). 
Presence of the full-length protein was also confirmed by mass spectrometry. HpFlgD_G27 
was prior mass analysis purified by RP-HPLC and major peak was isolated (Fig. 24). Mass 
spectrometry analysis confirmed that distinctive peak corresponds to 36178 Da. However, 
crystals of both forms (tetragonal, HpFlgD_t, and monoclinic, HpFlgD_m) contain a truncated 
form of HpFlgD. The proteolytic cleavage in HpFlgD proceeds much slower than in XcFlgD 
and PaFlgD where the crystals were obtained in 14 and 3 days, respectively, while in our case 
2 months were needed.12,14 
 
Figure 24. HPLC chromatogram of the full-length HpFlgD_G27. The major species present in 
the solution corresponds to the size of 36,178 Da. 
 
In both crystal structures the monomers comprise residues Asn127  Lys272, which are 
well defined from the electron density. It can be seen from the sequence that amino acid residues 
are missing in both N- and C-terminal regions (Fig. 19). The first 126 amino acid residues 
cannot be seen in the electron density map, as well as the last 29 amino acid residues in 
HpFlgD_t (strain 26695) and the last 44 residues in the case of HpFlgD_m (strain G27). It has 
been argued that the N-terminal region is susceptible of proteolytic cleavage due to some degree 
of flexibility.14 To determine whether these terminal parts were cleaved or are present in the 
crystal as disordered regions, some tetragonal crystals were dissolved and checked by SDS – 
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PAGE electrophoresis (Fig. 23a). The gel shows presence of two fragments corresponding to a 
size of about 17 kDa. These bands were extracted for the nanoESI mass spectra analysis, which 
confirmed presence of four peptides that started and ended at different residues within the range 
of Glu122Lys246 (Fig. 25). Despite the fact that a protease inhibitor cocktail was used during 
all of the steps of purification, after some time purifed HpFlgD contained degradation products 
(Fig. 23b). It is hard to state whether the cleavage is a consequence of the presence of a small 
amount of E. coli protease that could cleave flexible N- and C-ends of HpFlgD, or because of 
the protein instability that causes spontaneous degradation over time. 
 
 
Figure 25. Results of the mass spectrometry: the peptides found in full-length HpFlgD_26695 
are bolded in red, while the peptides found in the tetragonal crystal of HpFlgD_26695 are 
indicated by blue dotted lines. 
 
4.1.5. Structure of the FlgD monomer  
 
The two crystal forms are virtually identical, since the two strains, G27 (HpFlgD_m) and 26695 
(HpFlgD_t), differ in only 2 amino acids in the crystallized fragments (residues 257 and 268, 
Fig. 19). The root mean square deviation (r.m.s.d.) between 146 equivalent Cα atoms is 0.38 Å. 
HpFlgD, similarly to the other two FlgD structures previously determined,14,12 is composed of 
two separate domains (Fig. 26). Domain II is continuous along the polypeptide chain, spanning 
from residue 141 to 234, whilst domain I includes 14 residues at the N-terminus (from 127 to 
140) and all the remaining portion at the C-terminus, from 235 to 272. Lys272 is the last residue 
visible in the structure of both crystal forms.  
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Figure 26. Cartoon view of the HpFlgD_t monomer. Secondary structure elements of the tudor 
and Fn-III domains are colored in dark blue and light blue, respectively. This figure was 
produced using CCP4MG.47 
 
Domain I can be classified as belonging to the family of tudor domains, consisting of a 
strongly-bent five-strand β-barrel. Domain II can be defined as a fibronectin type III (Fn-III)-
like domain. In fibronectin the module consists of two layers of β-sheets, one with three 
antiparallel strands and the other with four antiparallel strands. In HpFlgD, the Fn-III domain 
forms a β-sandwich also made by seven antiparallel β-strands, however, one layer is composed 
of only two antiparallel strands while the other has five antiparallel strands. This is the 
consequence of the two main differences: β8-strand of HpFlgD does not overlap well with the 
last β-strand of the C-terminal domain in fibronectin; there is no overlap between the first β-
strand of the Fn-III domain in HpFlgD (β2-strand) and fibronectin, instead there is an overlap 
of the β2-strand of HpFlgD with the last β-strand of the C-terminal domain in fibronectin. The 
superposition of Cα atoms of domain II of HpFlgD with the fibronectin domain of 1FNA (Fig. 
27),137 the prototype of the family, gives a r.m.s.d. of 2.51 Å for 61 aligned residues. The Fn-
III domain is also found as one of the five domains in the streptococcal cell wall of C5a 
peptidase (PDB ID 1XF1), a highly specific protease and adhesin/invasin.138 Fibronectin, a 
multiple domains protein, can bind through a particular RGD motif in Fn-III domain to the 
specific cell membrane receptors, collagen, fibrin, and heparin,139 and is a possible substrate of 
adherence of microorganisms to the eukaryotic cells.140 Even though the flagellin component 
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D does not possess the common RGD motif, a similar tripeptide sequence (WDG) is found in 
the Fn-III domain of HpFlgD, as well as in the other two FlgD ortholuges (XcFlgD and PaFlgD, 
Fig. 19). Similar architecture of the Fn-III domain in human proteins and proteins from 
pathogenic bacteria could be relevant for the recognition of the human host cells (by the 
extracellular matrix proteins or integrins) by pathogens for adhering to the human gastric 
epithelial cells to set up a persistent infection. Moreover, sharing the same domain could imply 
the ability of HpFlgD to be involved not only in the control of the proper structural organization 
of the flagellar hook, but also directly in the H. pylori pathogenesis.  
 
 
Figure 27. Superposition of the Fn-III domain in fibronectin (yellow) (PDB entry ID 1FNA) to 
the same domain in HpFlgD_t (light blue). The r.m.s.d. for the superposition of 61 aligned C 
atoms of fibronectin on HpFlgD_t is 2.51 Å. This figure was produced using CCP4MG.47 
 
Differences of the inter-domain orientation in the crystal structures of HpFlgD and other 
FlgD homologues are described in the second paragraph below. 
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4.1.6. Quaternary structure and interfaces 
 
The quaternary structure in both crystal forms is a tetramer. Four monomers are present in the 
asymmetric unit of HpFlgD_m, corresponding to a molar volume (VM) of 2.61 Å3 Da1 and an 
approximate solvent content of 53 %. Monomers A and B, together with their pair related by a 
two-fold symmetry axis, form one tetramer (Fig. 28a). Another two monomers (C and D), from 
the asymmetric unit, with their pair related by a two-fold symmetry axis form other tetramer. 
In the structure of HpFlgD_t there is one monomer in the asymmetric unit, with a VM of 3.23 
Å3 Da1 and an approximate solvent content of 62 %. The tetramer is generated by the four-fold 
symmetry axis. The analysis of the interfaces by software PISA135 shows that the tetramer 
observed in the crystal corresponds to the molecule of truncated protein in solution. The surface 
area buried after tetramer formation corresponds to 3898 Å2, about 12.9 % of the total surface. 
Dimerization takes place through pairing of β-strand 9 and β-strand 12 of the two tudor domains 
from neighbouring monomers (Fig. 28b) giving rise to a continuous β-sheet between them. This 
is the largest interface area in the crystal structures of both HpFlgD_t and HpFlgD_m. This 
situation repeats four times, creating a network of hydrogen bonds and salt bridges between the 
four monomers (Table 34).  
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Figure 28. (a) HpFlgD_m tetramer (monomer A is shown in blue and B in gold color). (b) 
Monomers A and B in the structure of HpFlgD_m interconnected by hydrogen bonds (blue 
dashed bonds) with a close-up of the hydrogen bonds. This figure was produced using 
CCP4MG.47 
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Table 34. Hydrogen bonds (Å) between monomers that are relevant for their assembly into a 
tetramer.  
                                                      HpFlgD_t HpFlgD_m 
Monomer1···Monomer2Symmetry 
code 
A···A[y1, x,  z] B···A[x, y, z] A···B D···C[x, y, z] C∙∙∙D[x1, y, z1] 
Ile264 O            Phe244 N 2.71 2.92 2.75 3.07 2.83 
Phe266 N          Val242 O 2.88 2.82 2.80 2.94 2.90 
Phe266 O          Val242 N 3.01 2.87 2.92 2.89 3.03 
Glu265 OE2      Ser241 OG 2.93 3.36 3.20 3.15 3.17 
*Glu265 OE2    Arg 252 NH2 3.43 2.79 2.61 2.72 2.85 
*Denotes the salt bridge. 
 
In addition, the four N-termini of the chain present in the crystal pack together, filling the 
hole generated by tetramerization and giving rise to a compact structure that assumes the shape 
of a cap, with positive charges at the center of the convex surface, and positive charges at the 
concave center surrounded by negative charges on the surface (Fig. 29). An interface involving 
neighboring tudor domains is found also in other two homologous structures, labeled Type III 
in both of them, Fig. 30 (notation according to Kuo et al., 2008).14 However, there is a 
significant difference between Type III interface and the main interface in HpFlgD. Contrary 
to pairing of β-9 and β-12 strands in HpFlgD, there is paring of two neighboring β-9 strands in 
Type III (this numeration is according to HpFlgD to enable comparison). Type III interface is 
not favorable for tetramer formation since it forms dimers (the monomers are related by a two-
fold symmetry axis), contrary to the interface in HpFlgD where β-9 to β-12 pairing enables 
further pairing of the same kind and assembly into a tetramer. Interestingly, conserved residues 
are present only in the β-9 strand in all three FlgD protein structures (Fig. 19).  
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Figure 29. Qualitative electrostatic surface (represented as kb T e
1) of the tetramer, seen along 
the convex (on the left) and concave (on the right) surface. This figure was prepared with 
software PyMol.134 
 
 
Figure 30. Type of interface between the tudor domains present in the crystal structure of 
HpFlgD (a) and XcFlgD (b). This figure was produced using CCP4MG.47 
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Due to the shorter length of the β-12 strand in XcFlgD and PaFlgD than in HpFlgD a much 
smaller interface of the type β-9 to β-12 could only be formed, possibly not favourable for 
tetramer formation. Except for the main interface which is involved in the tetramer formation 
in HpFlgD the other three interfaces have smaller interface areas (Fig. 31, Table 35). None of 
these interfaces correspond to those in XcFlgD and PaFlgD, where interfaces of the Type I, II 
and III (notation according to (Kuo et al., 2008)14 are present. 
 
Figure 31. Different types of interfaces found between the molecules in the monoclinic crystal 
structure of HpFlgD (a, b, c) and in the tetragonal crystal structure of HpFlgD (d, e, f). This 
figure was produced using CCP4MG.47 
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Table 35. Different types of interfaces between the molecules in the crystal structure of 
HpFlgD. NHB and NSB refer to the number of hydrogen bonds and salt bridges, respectively. The 
interfaces labelled af with a superscript* are shown in Fig. 31, while the interface labelled as 
t* refers to the interface responsible for the tetramerization (as shown in Figs. 28b and 30).  
Crystal 
system 
Interface 
type 
Monomer1···Monomer2Symmetry 
code 
Interface area / Å2 NHB NSB 
Monoclinic      
 t* B···A[x, y, z] 521.9 7 3 
 t D···C[x, y, z] 492.5 6 2 
 t B···A[x, y, z] 492.1 7 2 
 t C···D[x1, y, z1] 494.8 8 3 
 a* C···B[x, y, z] 302.3   
 b* D···B[x+1, y,  z] 297.3 1 - 
 c* D···D[x, y1,  z] 280.1 1 5 
 c A···A[x, y1,  z] 268.2 1 5 
 c B···B[x, y1,  z] 216.4 3 5 
 c C···C[x, y1,  z] 194.3 3 5 
Tetragonal      
 t A···A[y+1, x, z] 478.8 12 2 
 d* A···A[x, y+1, z] 299.9 4 4 
 e* A···A[x,y+1,  z] 201.5 2  
 f* A···A[y1/2, x+1/2, z + 1/2] 119.2 4 4 
 
4.1.7. Comparison with other structures  
 
Identity of HpFlgD with PaFlgD and XcFlgD is 24 % and 20 %, respectively (Fig. 19). Despite 
this low sequence identity the three hook scaffolding components share common folds of each 
domain. However, the overall structure of each protein shows significant differences. In fact, 
Fn-III domain superimposes quite well with that of the orthologue FlgD from the other species 
(r.m.s.d.s are 2.17 Å for 93 residues in XcFlgD and 1.73 Å for 91 residues in PaFlgD). On the 
contrary, by superimposing HpFlgD_t and PaFlgD the larger Fn-III domains superimpose well, 
however it can be observed that the tudor domain in HpFlgD has a totally different orientation 
with respect to the tudor domain in PaFlgD (Fig. 32), and also with respect to this domain in 
XcFlgD which has the same orientation as in PaFlgD. The tudor domain by itself can be 
superposed quite well in all three homologues (Figure 33). Different relative orientation of 
domains in HpFlgD than in others could imply the presence of two distinct orientation modes 
with a switch between them happening as a part of the mechanism during its activation. 
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Figure 32. Stereoview of the superposed Cα chain trace of PaFlgD_A (red, PDB entry 3OSV;12 
on HpFlgD_t (gold). The r.m.s.d. for the superposition of 91 aligned C atoms of PaFlgD_A 
on HpFlgD_t is 1.73 Å. This figure was produced using CCP4MG.47 
 
 
Figure 33. Superposition of the tudor domain in HpFlgD_t (dark blue), XcFlgD (green) and 
PaFlgD_A (red). The r.m.s.d.s for the superposition of 47 aligned C atoms of XcFlgD on 
HpFlgD_t and 43 aligned C atoms of PaFlgD_A on HpFlgD_t are 2.09 Å and 1.55 Å, 
respectively. This figure was produced using CCP4MG.47 
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FlgD is the hook cap protein, a necessary component in the formation of the filament of the 
flagellum.141 To build the hook, FlgD must be assembled at the end of the rod structure,68 before 
another flagellin, FlgE, is secreted and placed underneath it. The crystal structure of FlgE (or 
at least of a proteolytic fragment) from Salmonella enterica subsp. enterica serovar 
Typhimurium has been determined (PDB ID 1WLG),62 and a low resolution image of the 
organization of the hook was obtained by electron microscopy: 120 copies of the flagellin are 
arranged in a helical structure, with about 12 molecules per turn. Interestingly, HpFlgD shares 
an architecture that roughly resembles that of HpFlgE, the protein that constitutes the hook of 
the flagellum. Superposition of HpFlgD to a model of HpFlgE built by homology by the 
software Phyre2 is shown in Fig. 34. The r.m.s.d for the superposition of Cα atoms is 3.44 Å for 
68 aligned residues, despite a sequence identity of less than 14 %. The most relevant aspect is 
that both HpFlgD and HpFlgE are composed of two domains, each of them with a similar 
architecture, despite both domains in HpFlgE being larger than the corresponding domains in 
HpFlgD. It can be speculated that this similarity could play some role in the mechanism of the 
hook assembly 
 
Figure 34. Stereoview of the superposed Cα chain trace of HpFlgD_t (gold) and the modeled 
HpFlgE (purple). The r.m.s.d. for the superposition of 68 aligned C atoms of modeled HpFlgE 
on HpFlgD_t is 3.44 Å. This figure was produced using CCP4MG.47 
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4.1.8. Proposed physiological role of truncated HpFlgD  
 
Proteome analysis identified HpFlgD in the H. pylori culture supernatant within the pool of the 
most represented secreted components.142,143 However, its function as well as processing has 
not been characterized so far. The N-terminal region of HpFlgD is susceptible to proteolytic 
cleavage, as confirmed by crystallized fragments (Fig. 23a). Analogous proteolytic events gave 
rise to crystals composed of only the C-terminal fragment in all FlgD structures characterized 
till now.12,14  
The N-terminal region (pfam03963), despite the fact that no typical features of a canonical 
export signal are present, is well conserved among the flagellar hook capping proteins family 
(cl15992). The HpFlgD N-terminal sequence is predicted to include an initial flexible segment 
(corresponding to residues 1 to 27) followed by two predicted helical motifs and a further 
disordered segment (93-116; Psi-pred server results). The presence of some helical content in 
HpFlgD is confirmed by the CD data of the entire protein (Fig. 22 and Table 33). The N-
terminal region is not only flexible and more prone to degradation, but has been demonstrated 
to be essential for the secretion in both Salmonella enterica and Escherichia coli variants. 
Indeed, the export signal of EcFlgD has been demonstrated to be comprised of the first N-
terminal 71 amino acids,70 while the first 100 amino acids of SeFlgD were proven to guarantee 
a secretion level equivalent to the full-length protein once expressed in fusion with a reporter 
gene.144 Such secretion signals are surprisingly longer than the canonical ones and do not show 
the typical Sec machinery consensus features.  
Another intriguing aspect of HpFlgD is that the residues at the C-terminus, after Lys272, 
are not visible in both of the crystal structures determined in this work. Indeed, all the sequences 
of FlgD homologues in any Helicobacter species deposited in the UniProt data bank present a 
peculiar and disordered fragment of variable length at the C-terminus. It is composed of repeats 
of five amino acid motifs according to the consensus sequence XQK(X)2 where the first position 
X is mainly present as D and E (rarely as N). The two last positions (X)2 can vary according to 
PI and PL or less often as LS and PQ. The conserved and repeated motifs vary only in terms of 
the number of repeats, while they are all followed by the sequence TPPKETA that represents, 
in the majority of cases, the very C-terminal fragment. Such a peculiar sequence of repeats is 
not present in the FlgD homologues of other bacteria and cannot be easily reconciled to a well-
known motif or signal. Nevertheless, the C-terminus of FliC protein, the flagellin subunit 
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defining the filament, is bound in an extended form by the FliS chaperone,145 preventing its 
premature polymerization. Such an interaction is a common strategy for flagellar export 
chaperones, to bind their substrates and control flagella biosynthesis. While no data has been 
acquired until now on the physiological role played by HpFlgD C-terminus, such a peculiar and 
highly conserved sequence suggests it could represent an interaction or recognition motif. A 
BLAST search throughout a non-redundant database of deposited sequences has shown that 
similar patterns can be identified in other bacterial or plasmodia proteins with quite different 
functions and in different positions in the primary structure, supporting the idea that it could 
represent a common mode of recognition of interaction partners, rather than a signal sequence. 
A relevant difference between HpFlgD and the other two FlgD homologues, whose 
structures are known, is represented by the quaternary organization. The entire HpFlgD is a 
dimer in solution, but it becomes a tetramer after cleavage of the N-terminus. This difference 
in the oligomerization state is likely due to the long flexible N-terminal portion, which is present 
in the purified protein, but is lost before crystallization. The latter apparently prevents 
tetramerization, since the N-termini in the form found in the crystal are in the center of the 
tetramer, in close proximity of the four-fold axis (Figs. 28a and 29). It is hard to say if the 
aggregation state of HpFlgD has some physiological meaning or if it represents an artifact of 
crystallization. However, previous considerations suggest that this cleavage has a functional 
significance, since the protein has to be exported into the outside space in order to interact with 
the hook, before the flagellum is fully formed. The flexible N-terminal part is also absent in the 
crystal structures of both PaFlgD and XcFlgD, strongly supporting the hypothesis that this part 
plays a role in the physiological mechanism of flagellar assembly. The N-terminal fragment 
could act as a signal for the export and the crystallized protein could correspond to the mature 
protein.  
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4.2. CrdA protein from H. pylori 
 
4.2.1. Cloning, expression and purification of StrepCrdA, CrdAHis and GSTCrdA 
 
Cloning without the first 22 amino acids was performed since the CrdA sequence analysis by 
the LipoP bionformatic tool (http://www.cbs.dtu.dk/services/LipoP/) predicted a cleavage site 
for an export signal and a lipidation site (aa 2223), Fig. 35. To determine whether the CrdA 
sequence possesses conserved regions for the binding of copper ions, the sequence was 
compared with the sequences of the CopC and PcoC. These proteins belong to the CopC family 
and are periplasmic proteins involved in process that results in a change in state or activity of a 
cell or an organism as a result of a copper ion stimulus. The alignment showed (Fig 35) that 
CrdA sequence contains conserved amino acids, mainly methionines, that could be involved in 
the copper binding. 
 
Figure 35. Sequence alignment of CrdA (HP, O25884), CopC (PS, P12376) and PcoC (EC, 
Q47454) using CLUSTAL OMEGA.130 The alignment figure was generated using ESPript 
3.0.136 The numbering system is based on the CrdA sequence. Residues conserved in all three 
sequences are labelled in white and highlighted in red, while similar residues are labelled in 
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black and highlighted in yellow. Possible ligands for the Cu(II) and Cu(I) sites in CopC and 
PcoC are marked with magenta and turquoise arrows, respectively.78 
 
In the case of the CrdAHis-tag and Strep-tagCrdA protein, high expression levels were 
obtained but with a poor solubility (Fig. 36a), so refolding methods were implemented with 
success. The insoluble portion of CrdA was denatured and then renatured by slow dilution. The 
best renaturation outcome was obtained using the buffer R6 (Fig. 38b) since after the affinity 
chromatography purification the flowthrough of refolded CrdA in buffer R6 contained the 
lowest amount of protein (Fig. 36c).  
 
 
 
Figure 36. SDSPAGE (a) StrepCrdA, Lane S  soluble fraction, Lane P – insoluble fraction; 
(b) Lanes R1 – R7 - refolded CrdAHis in different renaturation buffers (R1 – R7, see Table 28 
in section 3.7); (c) Lanes S1 – S7 – flow-through of CrdAHis in different renaturation buffers 
after the Ni-NTA affinity chromatography. 
 
The best condition for expressing the GSTCrdA protein was obtained when E. coli cells were 
grown at 16 C (Fig. 37a). As can be seen in Fig. 37b, SEC (Superdex 75 10/300 column) of 
cleaved GSTCrdA was successfully applied for the separation of the CrdA protein from the 
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GST-tag protein. This was possible since the GST protein is present as a dimer in the solution 
while CrdA as a monomer (see section 4.2.2.). 
 
 
Figure 37. SDS-PAGE (a) GSTCrdA (Molecular mass of the monomer  38 kDa); (b) cleaved 
GSTCrdA purified by SEC with lanes 1 – 4 and 5 – 6 corresponding to the GST (Molecular 
mass of the monomer  26 kDa) and CrdA (Molecular mass of the monomer  12.4 kDa) 
fractions, respectively. 
 
The proper folding of renaturated CrdA was confirmed by CD and 1D-NMR spectroscopy. 
The far-UV circular dichroism spectrum (Fig. 38a) shows a minimum at 214 nm and a peak of 
positive ellipticity for the values below 197 nm that are characteristic of a properly folded 
protein rich in  sheets (Table 36).108 The 1D NMR spectrum of refolded CrdA indicates 
presence of secondary structure elements (Fig. 38b) since the peaks in the spectrum are sharp 
and narrow and cover a large range of chemical shifts. and the spectrum also contains peaks in 
the negative ppm range. In an unfolded protein, a given proton does not have one distinct 
environment, so the peak is an average of all the different environments in which that proton is 
found. Also, the environments of different protons aren’t as distinct in an unfolded protein, so 
the peaks don’t cover a large range of chemical shifts. In a folded protein, most protons are 
more constrained in a distinct conformation, and the environment of each proton is very 
dependent on its position in the tertiary structure of the protein. 
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Figure 38. Refolded CrdA (a) CD spectrum of the StrepCrdA in the far UV region (195260 
nm) presented as ellipticity in milidegrees; (b) 1D NMR spectrum of the CrdAHis. 
 
Table 36. CD data of the StrepCrdA analysed by the secondary structure analysis software, 
CDNN.110 Deconvoluted results are shown as contributions of the various components to the 
protein secondary structure. 
SECONDARY STRUCTURE 
ELEMENT 
% 
Helix 9.0 
Antiparallel  sheet 35.6 
Parallel  sheet 5.2 
 turn 19.5 
Random coil 30.7 
 
4.2.2. Size of CrdA in solution 
 
Incubation of CrdA with copper(II) ions or EDTA, followed by SEC, was carried out. 
Recombinant His tagged CrdA treated with copper was eluted as a single peak at a volume of 
18.5 mL, while in case of CrdA treated with EDTA two different species were eluted: one at 
14 mL and the other one at 18.5 mL (Fig. 39). The calculated molecular mass from the SEC 
experiments of the CrdA species in the presence of copper ions was about 14.8 kDa that was in 
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close agreement with the predicted molecular mass that is 12.4 kDa. The observed molecular 
mass indicates that the CrdA protein treated with copper is present as a monomeric species in 
the solution, which is consistent with the behaviour of the copper binding PsCopC protein in 
the solution.78 In case of EDTA treatment, the CrdA protein eluted in two different oligomeric 
states - monomeric (14.8 kDa) and dimeric (31 kDa). Treatment with a metal chelating agent 
(EDTA) changed the behavior of CrdA, indicating that an equilibrium between the two different 
oligomeric species is present. 
 
 
Figure 39. Analytical gel filtration chromatogram of CrdA treated with Cu(II)+ ions (blue 
curve; Molecular mass of the monomer  12.4 kDa) which elutes as a single peak at the volume 
of 18.5 mL corresponding to the molecular mass of 14.8 kDa. CrdA chelated with EDTA (red 
curve) is composed of two different species that elute at 14 mL and 18.5 mL and correspond to 
the molecular mass of 31 kDa and 14.8 kDa, respectively. 
 
The monodispersity of the CrdA protein with and without addition of detergent was 
evaluated at a protein concentration of 2 mg mL1 and at 298 K by dynamic light scattering. As 
it can be seen in Fig. 40 the dispersity of the pure CrdA sample and of the CrdA sample treated 
with nOG detergent (c = 3.8 mmol L1) differs significantly. The solution of the CrdA protein 
without detergent was heterogeneous and contained species in different oligomeric states and 
with a high level of aggregation. The polydispersity index for the CrdA sample and CrdA plus 
nOG was 0.941 and 0.335, respectively, implying that only the sample treated with detergent 
could be used for the crystallization purpose. The influence of other detergents like LDAO (c 
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= 0.4 mmol L1) and DDM (c = 0.034 mmol L1) on the dispersity of CrdA was also tested 
(results not shown), however they only slightly affected the dispersity profile of CrdA. 
 
Figure 40. The volume distributions as a function of particle diameter: (a) CrdA and (b) CrdA 
treated with nOG detergent, c = 3.8 mmol L1. 
 
4.2.3. Affinity of CrdA towards copper(II) ions 
 
The copper binding properties of the CrdA protein were investigated by UV-VIS spectroscopy 
in the wavelength range 200800 nm. Fig. 41a shows presence of a broad absorption band at 
739 nm but unfortunately in these experiments saturation was not reached, Fig. 41b. The 
dissociation constant (Kd) for metal binding to the protein was determined from the titration to 
be 1.076  103 mol L1. Such a high value of the dissociation constant is characteristic of 
copper trafficking proteins rather than metalloproteins with an enzymatic function.146 Low 
affinity binding sites allow metal transfer to the recipient protein or enzyme while the high 
affinity sites prevent loss of the metal during redox cycling. Another possible explanation of 
such a high Kd is that the observed binding of copper(II) ions is unspecific, and maybe the 
preferable ligand for the CrdA protein is the Cu(I) ion. Based on the known crystal structures 
and the predictions for the Cu(II) and Cu(I) sites (Fig. 35) of similar copper binding proteins, 
CrdA could more likely accommodate Cu than Cu2 since its sequence is rich in methionines 
and lacks histidines and cysteines.78,79 
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Figure 41. (a) Change in the UV-VIS spectrum upon titration of CrdA (c = 152 mmol L1) in 
the phosphate buffer (30 mmol L1 Na2HPO4 pH 7, 50 mmol L
1 NaCl) with an increasing 
concentration of CuSO4. (b) Plot of A739 versus c(Cu
2). 
  
4.2.4. Crystallization of CrdA 
 
Purified samples of CrdA concentrated to 9 mg mL1 in complex with Cu(II) ions and 
supplemented with nOG were submitted to sparse matrix crystallization trials, applying the 
sitting drop vapor diffusion method, using an automated crystallization platform (Oryx8 robot). 
Each of the 686 independent crystallization conditions (Structure screen I & II, PEG’S II 
SUITE, PACT SUITE, JCSG CORE I-IV) were screened using the sitting drop setup on the 
MRC 2-well plates.  Prior to crystallization, the freshly purified protein was incubated with a 1 
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mmol L1 CuSO4 solution and 3.8 mmol L
1 nOG solution. In case of CrdAHis-tag  
microcrystals were observed (Fig. 42a, b) in the screening solution 32 of the PEG'S II SUITE 
(Qiagen) (0.1 mol L1 TRIS pH 8.5, 16 % PEG 4000) at 293 K. Diffraction data were measured 
at beamline ID23-1 of the ESRF synchrotron facility (Grenoble, France) but the small size of 
crystals limited the diffraction experiment (diffraction until the maximum resolution of 20 Å 
was observed). Other crystallization trials yielded drops containing aggregated forms or the 
phase-separation could be observed, so further optimization should be carried out. 
 
 
 
 
Figure 42. (a, b) Microcrystals of CrdA incubated with Cu(II) ions. Picture (b) was captured 
under the microscope using a fluorescence excitation filter (CWL / BW = 450 / 50 nm). 
 
4.3. HP1026 protein from H. pylori 
 
4.3.1. Expression, purification and size of HP1026 in solution 
 
His_HP1026 protein was overproduced in E. coli cells by growing the cell culture at 28 C and 
successfully purified by the Ni-NTA affinity chromatography followed by SEC (Superdex 200 
10/300), Fig. 43a, b. The resulting His_HP1026 from the SEC was 95% pure as clarified by 
SDS-PAGE gel (Fig. 43b) and was concentrated to more than 40 mg mL1. 
Fig. 43b shows that recombinant HP1026 was eluted in a single peak at the volume of 11.2 
mL which corresponded to the size of 96.9 kDa. Since the size of the HP1026 monomer is 43.8 
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kDa the calculated molecular mass from the analytical size-exclusion chromatography analysis 
correlates with a dimeric species in the solution. Even though most of proteins that belong to 
the AAA+ superfamily are present as hexamers in solution, some examples of lower 
oligomerization arrangement like tetrameric (EcMgsA),89 and dimeric (PfRFC)147 are known 
from the literature. Moreover, it is known for the EcMgsA protein and other similar clamp 
loader proteins that the C-terminal domain is responsible for the protein oligomerization.  
 
Figure 43. (a) SDS-PAGE of the HP1026 fractions eluted after the affinity chromatography; 
(b) Overlayed analytical gel filtration chromatograms of Apo_HP1026 (blue curve; molecular 
mass of the monomer 43.8 kDa) which elutes as a single peak at the volume of 11.2 mL 
corresponding to the molecular mass of 96.9 kDa and of HP1026 incubated with ATP--S (red 
curve) with a major peak eluted at 11.2 mL. SDS-PAGE of a pure and concentrated fraction of 
HP1026 after the SEC. 
 
4.3.2. Activity of HP1026 
 
The HP1026 sequence contains a conserved AAA+ motif (aa 36295, Fig. 44) which shows 
identity 94.2% with 250 H. pylori proteins classified as belonging to the AAA superfamily. 
The highest sequence similarity is found with the EcMgsA protein that contains a nucleotide 
binding site located at the N-terminus which is strongly conserved also in the sequence of 
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HP1026 (aa 4451, Fig. 44). To test whether HP1026 possesses an ATPase activity, ATP 
hydrolysis assay was carried. Performed experiments showed that HP1026 contains an ATPase 
activity (Fig. 45) within kinetic parameters as follows: Km= 344 mol L1, Vmax= 0.6019 mol 
L1 s1, kcat= 0.02 s
1. HP1026 hydrolyzed ATP at a lower level (0.02 s1) then it is measured 
for the EcMgsA protein in the absence of DNA (0.056 s1).89 However, in the case of EcMgsA, 
activity tests performed with addition of DNA significantly stimulated the  ATPase activity,89 
so in our case future studies will be required to determine whether HP1026 activity is also DNA 
dependent. 
 
Figure 44. Sequence alignment of HP1026 (HP, O25670) and MgsA (EC, P0A731) using 
CLUSTAL OMEGA.130 The alignment figure was generated using ESPript 3.0.136 The 
numbering system is based on the HP1026 sequence. Residues conserved in both sequences are 
labelled in white and highlighted in red, while similar residues are labelled in red. 
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Figure 45. ATPase activity of HP1026. Calculated parameters by applying the Michaelis-
Menten model were Km= 344 mol L1, Vmax= 0.6019 mol L1 s1 and kcat = 0.02 s1. 
 
 
4.3.3. Stability of HP1026 
 
CD measurements showed that both Apo_HP1026 and HP1026 protein incubated with ATP--
S demonstrate the typical profile of a protein rich in -helices having negative bands at 222 nm 
and 208 nm and a positive band around 190 nm (Fig. 46, Table 37).108 This result together with 
SEC profiles (Fig. 43b) indicates that addition of ATP--S did not alter the secondary structure 
profile nor the oligomerization profile of the HP1026 protein. 
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Figure 46. CD spectrum of the HP1026 in the far UV region (190260 nm) presented as 
ellipticity in milidegrees. Apo_HP1026, HP1026 incubated with ATP--S in a molar ratio 1:1 
and HP1026 incubated with ATP--S in a molar ratio 1:2 are presented as blue, red and green 
curves, respectively. 
 
Table 37. CD data of the HP1026 analyzed by the secondary structure analysis software, 
CDNN. Deconvoluted results are shown as contributions of the various components to the 
protein secondary structure. 
SECONDARY STRUCTURE 
ELEMENT 
% 
Helix 44.5 
Antiparallel  sheet 1.1 
Parallel  sheet 8.8 
 turn 14.9 
Random coil 30.7 
 
Thermal stability of HP1026 after addition of different additives, as well as without a His-
tag, was also investigated while the buffer condition was kept constant. Tm value for the 
HP1026:ADP, HP1026:ATP--S and HP1026:AMP complexes was at 49.75 (0.29) C, 48.09 
-40
-30
-20
-10
0
10
20
30
40
50
60
70
190 200 210 220 230 240 250 260

/m
d
e
g
/nm
§ 4. Results and Discussion 98 
Ivana Kekez Doctoral Thesis 
(0.03) C and 44.85 (0.09) C, respectively (Table 38). According to these values addition 
of AMP didn't change the Tm value of the HP1026 protein while the removal of His-tag slightly 
increased Tm by +1.38 C. From Fig. 47 and Table 38 it is evident that ATP--S and ADP 
strongly affected the protein stability by shifting the protein-complex denaturation to higher Tm 
values by +3.52 C and +5.18 C, respectively. The data after the ATP hydrolysis assay were 
another confirmation that HP1026 belongs to the class of ATPase proteins. The results of this 
thermofluor assay were also applied in the crystallization experiments. 
 
Figure 47. Effect of different additives and His-tag on the HP1026 thermal stability.  
 
Table 38. Melting temperatures of ApoHP1026 without His-tag, ApoHP1026 and HP1026 after 
addition of different additives. 
 
PROTEIN HP1026noHis HP1026 HP1026 HP1026 HP1026 
ADDITIVE   ATP--S ADP AMP 
Tm / C 45.95 (0.03) 44.57 (0.57) 48.09 (0.03) 49.75 (0.29) 44.85 (0.09) 
 
4.3.4. Crystallization of HP1026 
 
Good quality of the sample for the crystallization studies was confirmed by the DLS experiment 
(PDI < 0.12, Figure 50) for the HP1026 protein treated with 10 % (v/v) glycerol.  
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Figure 48. The volume distributions as a function of particle diameter of HP1026 after addition 
of 10 % (v/v) glycerol. 
 
Since the HP1026 protein was very soluble ( 40 mg mL1) it was hard to estimate which 
concentration was appropriate for the crystallization trials so the solubility profile of HP1026 
was explored. Using the solubility tool kit an optimal concentration of 15 mg mL1 was 
estimated to be suitable for the crystallization experiments. Screening of different 
crystallization conditions was performed by using commercial screening solutions, Structure 
screen I & II, PEG’S II SUITE, PACT SUITE and PGA Screen, by the sitting drop vapour 
diffusion method using an automated crystallization platform (Oryx8 robot). Crystallization 
drops were prepared by mixing the protein and precipitant solutions in a ratio 1:1, and 
equilibrated against 75 L of the mother liquor in the reservoir. The initial hexagonal shaped 
crystals were grown in a week at 20 C from different screening solutions of the PACT SUITE 
(Table 39). Crystals were very sensitive and had tendency to dissolve in time (Fig. 49c). 
Crystals were tested at the PXIII beamline of the Swiss Synchrotron Light Source (SLS, 
Villigen, Switzerland) with and without cryoprotectant solutions. Cryoprotectant solutions were 
prepared by mixing the precipitant solution and ethylene glycol / glycerol / oil in different 
percentages (v/v, 20 %, 25 %, 30 %). Crystals without cryoprotectant contained ice rings and 
didn’t diffract because they were destroyed during the freezing step in liquid nitrogen. Crystals 
that were frozen in the cryoprotectant solution were without ice rings but, unfortunately, 
diffracted only to 15 Å. During the diffraction experiment annealing was also tried but it didn’t 
help in ordering the molecules inside the crystal. A number of different ways were explored to 
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improve the diffraction quality. Microseeding resulted in too many small crystals while 
dehydration of the crystal, carried out by transferring the crystal from the crystallization drop 
into a drop of the dehydrating solution (containing 30 % of PEG 3350) which was then 
equilibrated against a 75 L volume of dehydrating solution, didn’t improve crystal quality. 
Crystallization at lower temperature was also tested but it resulted in drops containing only 
precipitation. 
 
Table 39. The PACT SUITE composition table of the conditions that gave crystals of HP1026. 
 
Condition number Composition 
43 0.2 mol L1 NaCl, 0.1 mol L1  TRIS pH 8.0, 20 % PEG 6000 
78 0.2 mol L1  NaOCOOH, 0.1 mol L1  BIS TRIS PROPANE pH 7.5, 20 % PEG 3350 
86 0.2 mol L1  NaBr, 0.1 mol L1  BIS TRIS PROPANE pH 8.5, 20 % PEG 3350 
88 0.2 mol L1  KSCN, 0.1 mol L1  BIS TRIS PROPANE pH 8.5, 20 % PEG 3350 
 
Taking into account all of the previous results together with the results of the protein 
stability investigation, the crystallization trials were carried out for HP1026 without His-tag 
and for HP1026 in complex with ATP--S or ADP. ATP--S was used instead of ATP since it 
is a non-hydrolyzable ATP analogue. The HP1026 protein solution, at the final concentration 
of 15 mg mL1, was incubated with ADP or ATP--S and MgCl2 at the final concentrations of 
2 mmol L1 and 5 mmol L1, respectively, for 2 h prior to the crystallization experiments. 
HP1026 lacking the His-tag failed to gave crystals while HP1026:ATP--S  and HP1026:ADP 
gave crystals. Optimization of HP1026:ATP--S and HP1026:ADP crystals was performed by 
varying the protein and precipitant ratio and by screening the effect of different additives. The 
best quality crystals were obtained for HP1026:ADP complex in a drop containing 2.5 L 
protein and 2 or 1.5 L precipitant solution (0.2 mol L1 NaBr, 0.1 mol L1 Bis-tris propane pH 
8.5, 20 % PEG 3350, 0.015 mmol L1 CYMAL-7) at  293(2) K (Fig. 49a,b).  
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Figure 49. Hexagonal crystals of HP1026-ADP (a, b) after 5 days, (c) after 3 weeks. 
 
Since the crystals were multiple crystals they were separated before freezing in liquid nitrogen. 
Crystals were also tested at the PXIII beamline (SLS, Villigen, Switzerland) and diffracted until 
7 Å which is still not enough for solving the phase problem, so further improvement should be 
done. 
 
 
 
 
 
 
§ 4. Results and Discussion 102 
Ivana Kekez Doctoral Thesis 
 
 
 
§ 5. Conclusions 103 
Ivana Kekez Doctoral Thesis 
§ 5. CONCLUSIONS 
Crystal structures of truncated forms of Helicobacter pylori FlgD from two different strains in 
two space groups, I422 and P2, have been solved, at 2.2 Å and 2.8 Å resolution, respectively. 
Analogously to Pseudomonas aeruginosa and Xanthomonas campestris FlgD proteins, 
crystallization experiments set up for the full-length protein resulted in crystals of a truncated 
form, lacking both N- and C-terminus ends. The crystal structures of the truncated FlgD show 
that the monomer is composed of a tudor and a fibronectin type III domain. The spatial 
orientation of the two domains in HpFlgD differs from that of the homologous FlgD family 
members, P. aeruginosa and X. campestris. Even though the full-length HpFlgD contains a 
long N-terminal region which does not show the typical features of a canonical export signal, 
results within this thesis, together with the bioinformatic studies, and the previously reported 
studies on the essential role of the N-terminal region for secretion in both S. enterica and E. 
coli, support the idea that the N-terminal part of the protein acts like an exporting signal. 
Another interesting aspect is that the C-terminal part of HpFlgD could represent a recognition 
motif for its partner. All these findings, together with the crystal structures of HpFlgD and the 
crystal structures of FlgD from other bacterial homologues, imply that functioning of FlgD 
requires proteolysis of the N-terminal pro-peptide. Finally, the structural differences of HpFlgD 
with respect to the homologous FlgD family members present in other bacteria suggest that 
significant differences exist in the molecular organization of the flagella in different bacterial 
species.  
Recombinant CrdA protein (His/Strep/GST tagged) was successfully overexpressed. In case 
of CrdA_His and Strep_CrdA proteins high expression levels were obtained but the protein had 
poor solubility, so denaturation and refolding methods were implemented with success. Circular 
dichroism and 1D NMR confirmed the presence of secondary structure elements with a major 
contribution of  sheets (60.3 %). Dynamic light scattering showed that nOG detergent prevents 
protein aggregation and reduces sample polydispersity. SEC of Cu:CrdA suggests that addition 
of copper(II) ions stabilize formation of uniform species shifting the equilibrium toward 
monomeric species. UV-VIS titration with copper(II) sulphate resulted with low Cu(II) affinity 
(Kd = 1.076  103 mol L1), a property of copper trafficking proteins, but it also implies that 
§ 5. Conclusions 104 
Ivana Kekez Doctoral Thesis 
since the CrdA protein is rich in methionines the affinity of Cu(I) should be tested. 
Crystallization trials gave only microcrystals that were not suitable for diffraction experiment 
so further optimization is needed. 
HP1026 was overexpressed, purified to homogeneity and biophysically characterized. Gel 
filtration profile indicated the presence of dimeric species in the solution for both Apo- and 
ATP--S treated HP1026, so no oligomerization step was observed after the addition of ATP-
-S. CD analysis showed that -helices are present as major secondary structure elements (44.5 
%). ATP hydrolysis assay confirmed the ATPase activity of a putative helicase like HP1026 
protein within kinetics parameters as follows: Km= 344 mol L1, Vmax= 0.6019 mol L1 s1, 
kcat= 0.02 s
1. These data together with the thermofluor assay for the first time demonstrate the 
role of the HP1026 protein as an ATPase. Good quality of the sample for the crystallization 
studies was confirmed by the DLS experiment (PDI < 0.12). Crystallization trials were carried 
out for Apo_HP1026, ATP--S:HP1026 and ADP:HP1026. The hexagonal shaped crystals 
were grown in a week at 20 C. Though not of good quality for diffraction analysis, these results 
outline a starting point for further crystallization trials. 
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§ 6. LIST OF ABBREVIATIONS 
ADP – Adenosine 5′-diphosphate 
AMP - Adenosine 5′-monophosphate 
ATP--S - Adenosine 5′-[γ-thio]triphosphate 
APS - Ammonium persulfate  
CV- Column volume 
DDM – n-Dodecyl--D-maltopyranoside 
dNTP- Deoxynucleotides 
DTT - 1,4-Dithio-D-threitol  
EDTA - Ethylenediaminetetraacetic acid 
HABA - 2-[4’-Hydroxy-benzeneazo] benzoic acid 
HEPES - 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
IPTG - Isopropyl-β-D-1-thiogalactopyranoside 
Km - Michaelis-Menten constant 
LDAO – N, N-Dimethyldodecylamine N-oxide 
MES - 2-(N-Morpholino)ethanesulfonic acid 
MPD - 2-Methyl-2,4-pentandiol 
nOG – n-Octyl--D-glucopyranoside 
PEG - Poly(ethylene glycol) 
PES – Polyethersulfone  
PMSF - Phenylmethylsulfonyl fluoride 
PTFE - Poly(tetrafluoroethylene)  
SDS – Sodium dodecyl sulfate 
SDS-PAGE - Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TBS – Tris-buffered saline TEMED – Tetramethylethylenediamine 
TRIS-base - Tris(hydroxymethyl)aminomethane 
TRIS-HCl - Tris(hydroxymethyl)aminomethane hydrochloride 
Vmax - maximum enzyme velocity 
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